Page last updated: 2024-10-30

methadone and Hepatitis C

methadone has been researched along with Hepatitis C in 231 studies

Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research Excerpts

ExcerptRelevanceReference
"Hepatitis C virus (HCV) is a prevalent chronic blood-borne infection among opioid-dependent patients on methadone maintenance treatment (MMT)."9.16Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. ( Acosta, A; Altice, FL; Bruce, RD; Eiserman, J; Gote, C; Lim, JK, 2012)
"Most methadone-maintained injection drug users (IDUs) have been infected with hepatitis C virus (HCV), but few initiate HCV treatment."9.15Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics. ( Arnsten, JH; Berg, KM; Hidalgo, J; Li, X; Litwin, AH, 2011)
"To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users."9.11Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. ( Dolan, KA; Kaldor, J; Shearer, J; White, B; Wodak, AD; Zhou, J, 2005)
"A prospective study was conducted on the evolution of serum transaminases in 116 patients infected with hepatitis C virus (HCV), parenteral drug abusers, included for 6 months in treatment programs with methadone, naltrexone or "drug free" regimen."9.08[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection]. ( Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA, 1997)
"Although hepatitis C virus (HCV) prevails in patients receiving methadone maintenance treatment (MMT), most do not receive anti-HCV therapy."8.12Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. ( Chan, HW; Chang, TT; Changchien, TC; Chen, CC; Chen, TH; Huang, CK; Lin, PC; Sie, YT; Tai, CM; Tsai, CT; Tseng, CH; Wang, DW; Yen, YC; Yu, ML, 2022)
"There is a dearth of research on hepatitis C virus (HCV) treatment uptake among people who inject drugs (PWIDs) and receive methadone substitution treatment (MST) in Eastern Europe and Central Asia countries."8.02Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia. ( Gamkrelidze, A; Getia, V; Gvinjilia, L; Khonelidze, I; Kuchuloria, T; Stvilia, K; Tsereteli, M; Vephkvadze, N, 2021)
"Despite the efforts to curb viral hepatitis and HIV infections through Methadone clinics, infection rates among people who use drugs are still high and the general knowledge on preventive measures is inadequate."8.02Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. ( Bakshi, FA; Gunda, DW; Jaka, H; Kalokola, F; Kilonzo, SB; Majinge, DC; Manyiri, PM; Mtui, G; Shao, ER; Stephano, A, 2021)
"People on methadone treatment have increased their life expectancy, aging prematurely with comorbidities."7.91[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health]. ( Gutiérrez-Cáceres, S; Pedraz-Marcos, A; Serrano-Gallardo, P, 2019)
"We aimed to evaluate the status and barriers related to hepatitis C virus (HCV) treatment among Chinese methadone maintenance treatment (MMT) clients, and the willingness and barriers of patients to accept directly observed treatment (DOT) service and oral direct-acting antivirals (DAAs)."7.91Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study. ( Chen, W; Gong, C; Ling, L; Liu, Y; Zou, X, 2019)
"Despite high hepatitis C virus (HCV) prevalence, opioid use disorder (OUD) patients on methadone rarely engage in HCV treatment."7.91Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. ( Andrews, P; Brown, LS; Chen, Y; Markatou, M; Mcleod, A; Sylvester, C; Talal, AH, 2019)
"The majority of patients undergoing methadone maintenance treatment (MMT) are neither examined nor treated for hepatitis C virus (HCV) infection."7.91Integrated care for methadone maintenance patients with hepatitis C virus infection. ( Bair, MJ; Chang, TT; Chuang, WL; Dai, CY; Huang, CF; Huang, JF; Tai, CM; Tseng, CH; Yeh, ML; Yen, YC; Yu, ML, 2019)
"To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China."7.85Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017)
"The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program."7.85Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017)
"Methadone maintenance treatment patients in Wuhan, China show a high prevalence of hepatitis C virus at admission (72."7.81Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China. ( Chawarski, MC; Desrosiers, A; Liu, M; Liu, P; Luo, L; Peng, J; Schottenfeld, R; Wang, X; Xie, N; Zhou, S; Zhou, W, 2015)
"This study explores the trends and associated factors of HIV, hepatitis C virus (HCV) and syphilis seroconversion among Chinese methadone maintenance treatment (MMT) clients over a follow-up period of up to 7 years."7.81Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. ( Ling, L; Zhang, L; Zou, X, 2015)
"To determine the relationship between methadone maintenance therapy (MMT) and hepatitis C (HCV) seroconversion among illicit drug users."7.80The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. ( Dias Lima, V; Fairbairn, N; Grebely, J; Kerr, T; Montaner, J; Nolan, S; Wood, E, 2014)
"This study investigates the prevalence and correlates of hepatitis C virus (HCV) infections among heroin dependent individuals who received methadone maintenance therapy in Taiwan."7.79High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. ( Chang, TJ; Chen, VC; Chou, JY; Gossop, M; Lee, PC; Lin, TY; Ng, MH; Shao, WC, 2013)
"Depression and hepatitis C virus (HCV) infection are two common conditions among heroin users in methadone maintenance treatment (MMT)."7.79Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. ( Du, J; Mandel, JS; Page, K; Wang, Z; Xiao, Z; Zhao, M, 2013)
"We used a 25-item, self-administered questionnaire to assess staff's perceived barriers and willingness to engage in onsite treatment of hepatitis C virus (HCV) at the Beth Israel Medical Center methadone maintenance treatment program (MMTP) at its Harlem sites."7.79Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. ( Des Jarlais, DC; Dimova, RB; Perlman, DC; Peterson, RH; Seewald, R; Talal, AH; Zeremski, M, 2013)
"This study aims to: (1) document the prevalence of hepatitis C virus (HCV) among methadone maintenance treatment (MMT) patients in Kunming and Shanghai; (2) examine risk factors for HCV by comparing those who tested positive with those who were negative and (3) examine if HCV serostatus is related to attitudes toward MMT."7.78Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. ( Chang, YJ; Du, J; Evans, E; Hser, Y; Li, J; Peng, CY; Zhao, M, 2012)
"The aim was to investigate hepatitis C virus (HCV) knowledge and alcohol consumption among patients (n = 114) in a methadone maintenance treatment (MMT) clinic in Shanghai."7.78Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China. ( Du, J; Wang, Z; Xie, B; Zhao, M, 2012)
"To provide evidence for policy makers for human immunodeficiency virus (HIV) prevention and control, we investigated HIV, syphilis, and hepatitis C virus (HCV) infection and the availability of methadone maintenance treatment (MMT) among migrant drug users in Beijing."7.78High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing. ( Cao, X; Chu, P; Jia, Z; Li, D; Li, S; Liu, Z; Lu, L; Ruan, Y; Yang, Y, 2012)
"To study the risk factors for seroconversion to hepatitis C virus (HCV) infection since admission to methadone maintenance treatment (MMT) and to characterize the seronegative admitted group."7.77Low risk for hepatitis C seroconversion in methadone maintenance treatment. ( Adelson, M; Peles, E; Rados, V; Schreiber, S, 2011)
"Hepatitis C virus (HCV) knowledge, attitudes, beliefs, and experiences (KABE) of 64 HCV antibody positive methadone maintenance treatment (MMT) patients were assessed in conjunction with acceptability of an on-site semi-structured HCV education session, HCV RNA diagnostic testing, HCV treatment motivational assessment, and initiation of HCV treatment."7.76Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. ( Batki, SL; Canfield, KM; Smyth, E, 2010)
" We report the case of a 50-year-old man with hepatitis C cirrhosis who demonstrated dramatic improvement in HPS after withdrawal from chronic methadone therapy."7.76Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. ( Lau, EM; McCaughan, G; Torzillo, PJ, 2010)
"To describe the patterns of screening for hepatitis C virus (HCV) infection in methadone-maintained pregnant women and their infants."7.75Screening for hepatitis C virus infection in methadone-maintained mothers and their infants. ( An, EI; Leroi, MJ; Liu, AJ; Murray, HG; Nanan, RK; Tetstall, E, 2009)
"The purpose of this article was to investigate the personal and social barriers experienced by methadone maintained clients when seeking treatment for alcohol abuse along with strategies for engaging such clients in treatment programs."7.74Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection. ( Cohen, A; de Castro, V; Khalilifard, F; Marfisee, M; McNeese-Smith, D; Nyamathi, A; Nyamathi, K; Shoptaw, S, 2008)
"We examined the impact of methadone maintenance treatment (MMT) on risk behaviors for transmission of blood-borne diseases in polydrug users who had tested positive or negative for hepatitis C virus (HCV)."7.74Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. ( Belendiuk, KA; Epstein, DH; Preston, KL; Schmittner, J; Willner-Reid, J, 2008)
"Despite the high prevalence of hepatitis C virus (HCV) infection among drug users enrolled in methadone maintenance treatment programs, few drug users are being treated with combination therapy."7.73Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. ( Gourevitch, MN; Litwin, AH; Soloway, I, 2005)
"The safety, efficacy, and tolerability of nelfinavir (NFV)-containing antiretroviral therapy were evaluated in patients coinfected with HIV and hepatitis C undergoing methadone maintenance at an urban outpatient opioid treatment program serving a minority adult population."7.73Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance. ( Brown, LS; Chu, M; Kritz, S; Madray, C, 2006)
"The survey of viral infections in the liver investigated by means of serological markers of hepatitis A, B and C in drug addicts on methadone maintenance treatment is important for the next procedures."7.72[Prevalence of serological markers of viral hepatitis B and hepatitis C in drug-dependent individuals treated at the Drop Methadone Center in Prague]. ( Urbánek, P; Wilczek, H, 2003)
" Hepatitis C virus (HCV) is highly prevalent among intravenous drug users (IDUs) and the 'offer' of a serological test for HCV antibodies is now seen as a national standard within drug misuse services, including GP methadone clinics."7.72Finding a vein or obtaining consent: a qualitative study of hepatitis C testing in GP methadone clinics. ( Chew-Graham, C; Perry, M, 2003)
"The cost-effectiveness of hepatitis C virus (HCV) anti-viral therapy for injecting drug users (IDUs) on methadone maintenance is important because the majority have chronic infections that remain untreated."7.72What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand? ( Green, FT; Sellman, JD; Sheerin, IG, 2004)
"The prevalence of human immunodeficiency virus (HIV) infection and hepatitis B, C, and G virus infections was determined in a selected group of 40 intravenous drug addicts on methadone maintenance treatment."7.72Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. ( Baklan, Z; Gorisek, JR; Pisec, A; Poljak, M, 2004)
"To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT)."7.71Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. ( Borg, L; Ho, A; Kreek, MJ; Lin, A; Melia, D; Piccolo, P, 2002)
"This study measured the extent and examined implications of hepatitis C (HCV) infection in a methadone maintenance treatment (MMT) population."7.71Hepatitis C in methadone maintenance patients: prevalence and public policy implications. ( Flynn, N; McCarthy, JJ, 2001)
"The high rates of hepatitis B exposure in injecting drug users on methadone treatment confirm the need for hepatitis B vaccination, particularly in view of their endemic hepatitis C infection."7.71Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination. ( Carter, H; Hailwood, C; Hanlon, C; Massarotto, A; Robinson, G, 2001)
"This study evaluates the safety, tolerability, and efficacy of interferon/ribavirin combination therapy in methadone maintenance (MM) patients with active hepatitis C (HCV)."7.71Treating hepatitis C in methadone maintenance patients: an interim analysis. ( Sylvestre, DL, 2002)
" We studied the associations between retention in methadone treatment and drug use behaviors and incidence of hepatitis B and C in a cohort of IDUs in the Seattle, Washington, area."7.70Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. ( Hagan, H; Murrill, CS; Thiede, H, 2000)
"The objective of this study was to describe the incidence and prevalence of hepatitis C infection among clients of a methadone program in Queensland."7.69Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. ( Denton, M; Plant, AJ; Selvey, LA, 1997)
" Multivariate linear regression to assess correlates of HCV knowledge post-intervention revealed that optimal dosage of MMT and having had an HIV test in the past year significantly increased HCV knowledge."6.84Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. ( Ali, SH; Altice, FL; Kamarulzaman, A; Mukherjee, TI; Pillai, V; Wickersham, JA, 2017)
"Individuals with opioid use disorders, including those on medication-assisted therapy such as methadone or buprenorphine, are a key demographic group that can benefit from HCV treatment given their high HCV prevalence; however, pharmacokinetic and pharmacodynamic drug interactions could blunt their utility."6.53Drug interactions between buprenorphine, methadone and hepatitis C therapeutics. ( Bruce, RD; Friedland, G; Ogbuagu, O, 2016)
"all methadone users that were positive for anti-HCV antibodies were included in the study."5.56Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa. ( Almandoz Cortajarena, E; Arenas Ruiz-Tapiador, J; Arranz Díaz, S; Bujanda, L; Castiella Eguzkiza, A; Chouza Pérez, JM; Esandi González, FJ; Gil Fernández, B; Gómez García, A; Pérez Castaño, Y; Sánchez Iturri, MJ; Sanz Largo, V; Urtasun Lugea, I, 2020)
"Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module."5.48Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018)
"A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004."5.46Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017)
"Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls."5.42Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015)
"Methadone maintenance treatment (MMT) is a major treatment regimen for opioid dependence."5.39Hepatitis C virus infection influences the S-methadone metabolite plasma concentration. ( Chang, YS; Ho, IK; Hsu, YT; Kuo, HW; Liu, SW; Liu, YL; Tsou, HH; Wang, SC; Wu, SL, 2013)
"Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006."5.39High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013)
"Methadone maintenance treatment program patients were referred, evaluated by the internist and hepatologist in hepatitis clinic and provided HCV treatment with integration between both sites."5.38Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance. ( Beeder, AB; Dimova, R; Kreek, MJ; Marks, KM; Martinez, AD; Talal, AH; Zeremski, M, 2012)
"For methadone, there was a non-significant 41 % increased advanced fibrosis risk in Whites and 51 % reduced risk in AA."5.38Finasteride and methadone use and risk of advanced hepatitis C related liver disease. ( El-Serag, HB; Hashmi, A; Kuzniarek, J; Ramsey, DJ; Tavakoli-Tabasi, S; White, DL, 2012)
"57% had a current non-substance use psychiatric disorder."5.35Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. ( Batki, SL; Canfield, KM; Ploutz-Snyder, R; Smyth, E, 2009)
"Methadone maintenance therapy for the treatment of opioid dependence continues to carry a social stigma."5.34Liver transplant and hepatitis C in methadone maintenance therapy: a case report. ( Bourgeois, JA; Craemer, E; Hancock, MM; Lester, L; Prosser, CC; Ransibrahmanakul, K; Rossaro, L, 2007)
"Methadone maintenance treatment reduces drug-related-harm."5.32[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]. ( Aragonés, A; Barril, J; Esteban, J; Gimeno, C; Pellín, Mde L, 2003)
" However, there are no special HCV or HIV (human immunodeficiency virus)-related intervention programs that are tailored for drug users in China; to fill this gap, the purpose of this study was to explore HCV and HIV-related knowledge among drug users in MMT (methadone maintenance treatment) sites of China and to investigate the effectiveness of HCV and HIV-related education for improving the knowledge of IDUs (injection drug users) and their awareness of infection."5.30DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China. ( Du, J; Huang, LP; Li, Z; Li, ZB; Wang, J; Zhan, GL; Zhang, JY; Zhang, L; Zhao, M, 2019)
"Hepatitis C virus (HCV) is a prevalent chronic blood-borne infection among opioid-dependent patients on methadone maintenance treatment (MMT)."5.16Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. ( Acosta, A; Altice, FL; Bruce, RD; Eiserman, J; Gote, C; Lim, JK, 2012)
"To examine hepatic enzyme test results throughout the course of pregnancy in women maintained on methadone or buprenorphine."5.16Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication. ( Coyle, MG; Heil, SH; Holbrook, AM; Jones, HE; Kaltenbach, K; Martin, PR; McNicholas, LF; O'Grady, KE; Stine, SM, 2012)
"Most methadone-maintained injection drug users (IDUs) have been infected with hepatitis C virus (HCV), but few initiate HCV treatment."5.15Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics. ( Arnsten, JH; Berg, KM; Hidalgo, J; Li, X; Litwin, AH, 2011)
" There was screening for patients attending general practice for methadone maintenance treatment for hepatitis C and referral of anti-HCV antibody positive patients to a specialist hepatology department for assessment."5.12Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation. ( Bury, G; Cullen, W; Kelly, Y; Langton, D; Staines, A; Stanley, J, 2006)
"To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users."5.11Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. ( Dolan, KA; Kaldor, J; Shearer, J; White, B; Wodak, AD; Zhou, J, 2005)
"A prospective study was conducted on the evolution of serum transaminases in 116 patients infected with hepatitis C virus (HCV), parenteral drug abusers, included for 6 months in treatment programs with methadone, naltrexone or "drug free" regimen."5.08[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection]. ( Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA, 1997)
" After adjusting for on or off MMT, age, sex, marital status, education level, maximum methadone dose, and comorbidities (human immunodeficiency virus, depression, hepatitis C virus, hepatitis B virus, alcoholic liver disease, and cardiovascular disease), the long group had a lower risk of death (hazard ratio = 0."4.31Reduced mortality in patients with extended duration of methadone maintenance treatment: a five-year retrospective nationwide study. ( Ho, IK; Huang, CL; Lee, CW; Lin, CL; Lin, WC; Tsai, IJ; Wang, RY, 2023)
"Although hepatitis C virus (HCV) prevails in patients receiving methadone maintenance treatment (MMT), most do not receive anti-HCV therapy."4.12Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. ( Chan, HW; Chang, TT; Changchien, TC; Chen, CC; Chen, TH; Huang, CK; Lin, PC; Sie, YT; Tai, CM; Tsai, CT; Tseng, CH; Wang, DW; Yen, YC; Yu, ML, 2022)
"To determine the prevalence of continued illicit drug use among people enrolled in methadone maintenance treatment (MMT), the association between hepatitis C status and methadone dosage, and the predictors for illicit drug abstinence during MMT."4.12Methadone Maintenance Treatment for Opioid Dependents: a Retrospective Study. ( Abdul Rashid, Q; Jamaluddin, R; Khalid, K; Mohammad Yusoff, MZA; Ooi, YT, 2022)
"There is a dearth of research on hepatitis C virus (HCV) treatment uptake among people who inject drugs (PWIDs) and receive methadone substitution treatment (MST) in Eastern Europe and Central Asia countries."4.02Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia. ( Gamkrelidze, A; Getia, V; Gvinjilia, L; Khonelidze, I; Kuchuloria, T; Stvilia, K; Tsereteli, M; Vephkvadze, N, 2021)
"Despite the efforts to curb viral hepatitis and HIV infections through Methadone clinics, infection rates among people who use drugs are still high and the general knowledge on preventive measures is inadequate."4.02Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. ( Bakshi, FA; Gunda, DW; Jaka, H; Kalokola, F; Kilonzo, SB; Majinge, DC; Manyiri, PM; Mtui, G; Shao, ER; Stephano, A, 2021)
"The aim of this study was to determine the influence of ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms on methadone metabolism in patients with hepatitis C virus (HCV) undergoing methadone maintenance treatment (MMT)."3.96ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients. ( Ključević, Ž; Kuret, S; Sutlović, D, 2020)
"People on methadone treatment have increased their life expectancy, aging prematurely with comorbidities."3.91[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health]. ( Gutiérrez-Cáceres, S; Pedraz-Marcos, A; Serrano-Gallardo, P, 2019)
"While most methadone maintenance treatment (MMT) patients have hepatitis C (HCV), less than 11% initiate treatment."3.91Perceptions of Barriers and Benefits of HCV Treatment and Correlates to Treatment Intention in Methadone Patients. ( Bass, SB; Gashat, MT; Gutierrez, M; Jessop, AB, 2019)
"We aimed to evaluate the status and barriers related to hepatitis C virus (HCV) treatment among Chinese methadone maintenance treatment (MMT) clients, and the willingness and barriers of patients to accept directly observed treatment (DOT) service and oral direct-acting antivirals (DAAs)."3.91Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study. ( Chen, W; Gong, C; Ling, L; Liu, Y; Zou, X, 2019)
"Despite high hepatitis C virus (HCV) prevalence, opioid use disorder (OUD) patients on methadone rarely engage in HCV treatment."3.91Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. ( Andrews, P; Brown, LS; Chen, Y; Markatou, M; Mcleod, A; Sylvester, C; Talal, AH, 2019)
"The majority of patients undergoing methadone maintenance treatment (MMT) are neither examined nor treated for hepatitis C virus (HCV) infection."3.91Integrated care for methadone maintenance patients with hepatitis C virus infection. ( Bair, MJ; Chang, TT; Chuang, WL; Dai, CY; Huang, CF; Huang, JF; Tai, CM; Tseng, CH; Yeh, ML; Yen, YC; Yu, ML, 2019)
"An estimated 70-90% of current methadone users have Hepatitis C (HCV)."3.88Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. ( Al Hajji, M; Bass, SB; Gashat, M; Gutierrez, M; Jessop, A; Maurer, L, 2018)
"Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections among methadone maintenance treatment (MMT) participants remain high."3.88Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study. ( Chen, W; Gong, C; Ling, L; Liu, Y; Xia, Y; Xu, Y; Zou, X, 2018)
"This paper describes the development of a mobile health tool to facilitate Hepatitis C (HCV) treatment decision making in methadone patients."3.88Take Charge, Get Cured: The development and user testing of a culturally targeted mHealth decision tool on HCV treatment initiation for methadone patients. ( Alhajji, M; Bauerle Bass, S; Forry, J; Gashat, M; Jessop, A; Maurer, L, 2018)
"To assess trends and related factors in HIV and/or hepatitis C virus (HCV) antibody testing and infection among injection drug users (IDUs) newly entering methadone maintenance treatment (MMT) in Guangdong Province, China."3.85Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. ( Chen, W; Ling, L; Liu, Y; Zou, X, 2017)
"The aim of this study was to characterize the epidemiology and disease related to hepatitis C in a population attending a low-threshold methadone program."3.85Hepatitis C in a Mobile Low-Threshold Methadone Program. ( Água-Doce, I; Balsa, C; Belo, E; Coutinho, R; Lopes, P; Loureiro, R; Martins, HC; Pádua, E; Pereira, C; Silva, MJ, 2017)
"Methadone maintenance treatment patients in Wuhan, China show a high prevalence of hepatitis C virus at admission (72."3.81Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China. ( Chawarski, MC; Desrosiers, A; Liu, M; Liu, P; Luo, L; Peng, J; Schottenfeld, R; Wang, X; Xie, N; Zhou, S; Zhou, W, 2015)
"Routinely collected data included: demographic information; drug use, sexual and criminal behaviours; status of infection with human immunodeficiency virus (HIV), hepatitis C virus (HCV) and syphilis; random urine-opiate test results; and the daily methadone dose received."3.81Who uses methadone services in China? Monitoring the world's largest methadone programme. ( Cao, X; Liu, E; Luo, W; Mi, G; Pang, L; Rou, K; Sullivan, SG; Wang, C; Wu, Z; Yin, W, 2015)
"This study explores the trends and associated factors of HIV, hepatitis C virus (HCV) and syphilis seroconversion among Chinese methadone maintenance treatment (MMT) clients over a follow-up period of up to 7 years."3.81Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. ( Ling, L; Zhang, L; Zou, X, 2015)
"Prior research has demonstrated neuropsychological (NP) impairment in persons with histories of injection drug use (IDU), hepatitis C virus (HCV) infection, and methadone maintenance treatment (MMT), individually, but little is known about the NP effects of these three risk factors in combination."3.80Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. ( Duarte, N; Franklin, DR; Grant, I; Gupta, S; Hampton Atkinson, J; Heaton, RK; Iudicello, JE; Jin, H; Knight, A; Letendre, S; Li, J; Riggs, PK; Shi, C; Wu, Z; Yu, X, 2014)
"The objective of this study was to assess craving and mood related to opioid and cocaine use among asymptomatic hepatitis C virus (HCV)+ and HCV- methadone patients who have not started antiviral treatment."3.80Substance use and hepatitis C: an ecological momentary assessment study. ( Epstein, DH; Lin, JL; Mezghanni, M; Phillips, KA; Preston, KL; Vahabzadeh, M, 2014)
"To determine the relationship between methadone maintenance therapy (MMT) and hepatitis C (HCV) seroconversion among illicit drug users."3.80The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. ( Dias Lima, V; Fairbairn, N; Grebely, J; Kerr, T; Montaner, J; Nolan, S; Wood, E, 2014)
"This study investigates the prevalence and correlates of hepatitis C virus (HCV) infections among heroin dependent individuals who received methadone maintenance therapy in Taiwan."3.79High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. ( Chang, TJ; Chen, VC; Chou, JY; Gossop, M; Lee, PC; Lin, TY; Ng, MH; Shao, WC, 2013)
"Depression and hepatitis C virus (HCV) infection are two common conditions among heroin users in methadone maintenance treatment (MMT)."3.79Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China. ( Du, J; Mandel, JS; Page, K; Wang, Z; Xiao, Z; Zhao, M, 2013)
"We used a 25-item, self-administered questionnaire to assess staff's perceived barriers and willingness to engage in onsite treatment of hepatitis C virus (HCV) at the Beth Israel Medical Center methadone maintenance treatment program (MMTP) at its Harlem sites."3.79Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. ( Des Jarlais, DC; Dimova, RB; Perlman, DC; Peterson, RH; Seewald, R; Talal, AH; Zeremski, M, 2013)
"This study aims to: (1) document the prevalence of hepatitis C virus (HCV) among methadone maintenance treatment (MMT) patients in Kunming and Shanghai; (2) examine risk factors for HCV by comparing those who tested positive with those who were negative and (3) examine if HCV serostatus is related to attitudes toward MMT."3.78Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. ( Chang, YJ; Du, J; Evans, E; Hser, Y; Li, J; Peng, CY; Zhao, M, 2012)
"The aim was to investigate hepatitis C virus (HCV) knowledge and alcohol consumption among patients (n = 114) in a methadone maintenance treatment (MMT) clinic in Shanghai."3.78Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China. ( Du, J; Wang, Z; Xie, B; Zhao, M, 2012)
"To provide evidence for policy makers for human immunodeficiency virus (HIV) prevention and control, we investigated HIV, syphilis, and hepatitis C virus (HCV) infection and the availability of methadone maintenance treatment (MMT) among migrant drug users in Beijing."3.78High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing. ( Cao, X; Chu, P; Jia, Z; Li, D; Li, S; Liu, Z; Lu, L; Ruan, Y; Yang, Y, 2012)
" Data on HIV and hepatitis C virus (HCV) infections, methadone dosage, and morphine in the urine were retrieved from patient files on the clinical premises, with permission of the participants."3.77Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. ( Chou, YC; Chuang, P; Huang, CW; Lee, TS; Liu, YL; Shen, HC; Shih, CY; Wang, BE; Wu, WH; Yen, MY, 2011)
"To study the risk factors for seroconversion to hepatitis C virus (HCV) infection since admission to methadone maintenance treatment (MMT) and to characterize the seronegative admitted group."3.77Low risk for hepatitis C seroconversion in methadone maintenance treatment. ( Adelson, M; Peles, E; Rados, V; Schreiber, S, 2011)
" Additional factors associated with BMD decline were: postmenopausal status, lower BMI, and methadone use at the lumbar spine; postmenopausal status and hepatitis C seropositivity at the femoral neck; and postmenopausal status, age, smoking, and lower BMI at the total hip (all p<."3.77Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. ( Cohen, HW; Freeman, R; Santoro, N; Schoenbaum, EE; Sharma, A, 2011)
"Hepatitis C virus (HCV) knowledge, attitudes, beliefs, and experiences (KABE) of 64 HCV antibody positive methadone maintenance treatment (MMT) patients were assessed in conjunction with acceptability of an on-site semi-structured HCV education session, HCV RNA diagnostic testing, HCV treatment motivational assessment, and initiation of HCV treatment."3.76Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. ( Batki, SL; Canfield, KM; Smyth, E, 2010)
" We report the case of a 50-year-old man with hepatitis C cirrhosis who demonstrated dramatic improvement in HPS after withdrawal from chronic methadone therapy."3.76Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism. ( Lau, EM; McCaughan, G; Torzillo, PJ, 2010)
"To describe the patterns of screening for hepatitis C virus (HCV) infection in methadone-maintained pregnant women and their infants."3.75Screening for hepatitis C virus infection in methadone-maintained mothers and their infants. ( An, EI; Leroi, MJ; Liu, AJ; Murray, HG; Nanan, RK; Tetstall, E, 2009)
"The purpose of this article was to investigate the personal and social barriers experienced by methadone maintained clients when seeking treatment for alcohol abuse along with strategies for engaging such clients in treatment programs."3.74Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection. ( Cohen, A; de Castro, V; Khalilifard, F; Marfisee, M; McNeese-Smith, D; Nyamathi, A; Nyamathi, K; Shoptaw, S, 2008)
"We examined the impact of methadone maintenance treatment (MMT) on risk behaviors for transmission of blood-borne diseases in polydrug users who had tested positive or negative for hepatitis C virus (HCV)."3.74Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance. ( Belendiuk, KA; Epstein, DH; Preston, KL; Schmittner, J; Willner-Reid, J, 2008)
"Prevalence of buprenorphine injection, associations with location, buprenorphine as prescribed pharmacotherapy, markers of hepatitis C virus (HCV) exposure and risk behaviours for HCV."3.74Buprenorphine injection in Melbourne, Australia--an update. ( Aitken, CK; Hellard, ME; Higgs, PG, 2008)
"Despite the high prevalence of hepatitis C virus (HCV) infection among drug users enrolled in methadone maintenance treatment programs, few drug users are being treated with combination therapy."3.73Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. ( Gourevitch, MN; Litwin, AH; Soloway, I, 2005)
"The majority of injecting drug users in Ireland are infected with hepatitis C (HCV) and many attend general practice for methadone maintenance treatment."3.73Experience of hepatitis C among current or former heroin users attending general practice. ( Bury, G; Cullen, W; Kelly, Y; Langton, D; Stanley, J, 2005)
"The safety, efficacy, and tolerability of nelfinavir (NFV)-containing antiretroviral therapy were evaluated in patients coinfected with HIV and hepatitis C undergoing methadone maintenance at an urban outpatient opioid treatment program serving a minority adult population."3.73Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance. ( Brown, LS; Chu, M; Kritz, S; Madray, C, 2006)
" Severity of psychological distress was related to current substance-related diagnoses, benzodiazepine abuse, higher methadone dosage, risk-taking behavior and the presence of hepatitis C."3.73Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. ( Adelson, M; Bleich, A; Gelkopf, M; Melamed, Y; Weizman, T, 2006)
"The survey of viral infections in the liver investigated by means of serological markers of hepatitis A, B and C in drug addicts on methadone maintenance treatment is important for the next procedures."3.72[Prevalence of serological markers of viral hepatitis B and hepatitis C in drug-dependent individuals treated at the Drop Methadone Center in Prague]. ( Urbánek, P; Wilczek, H, 2003)
" Hepatitis C virus (HCV) is highly prevalent among intravenous drug users (IDUs) and the 'offer' of a serological test for HCV antibodies is now seen as a national standard within drug misuse services, including GP methadone clinics."3.72Finding a vein or obtaining consent: a qualitative study of hepatitis C testing in GP methadone clinics. ( Chew-Graham, C; Perry, M, 2003)
"Approximately 85% of patients receiving methadone maintenance therapy (MMT) for opiate dependence in the United States are infected with hepatitis C virus (HCV)."3.72A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. ( Atanda, A; Barnett, R; DePiano, M; Lynch, KG; Olthoff, KM; Weinrieb, RM, 2004)
"The cost-effectiveness of hepatitis C virus (HCV) anti-viral therapy for injecting drug users (IDUs) on methadone maintenance is important because the majority have chronic infections that remain untreated."3.72What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand? ( Green, FT; Sellman, JD; Sheerin, IG, 2004)
"The prevalence of human immunodeficiency virus (HIV) infection and hepatitis B, C, and G virus infections was determined in a selected group of 40 intravenous drug addicts on methadone maintenance treatment."3.72Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. ( Baklan, Z; Gorisek, JR; Pisec, A; Poljak, M, 2004)
"To investigate hepatitis C (HCV) and human immunodeficiency virus (HIV-1) prevalence in former opiate or heroin addicts currently in methadone maintenance treatment (MMT)."3.71Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. ( Borg, L; Ho, A; Kreek, MJ; Lin, A; Melia, D; Piccolo, P, 2002)
"This study measured the extent and examined implications of hepatitis C (HCV) infection in a methadone maintenance treatment (MMT) population."3.71Hepatitis C in methadone maintenance patients: prevalence and public policy implications. ( Flynn, N; McCarthy, JJ, 2001)
"The high rates of hepatitis B exposure in injecting drug users on methadone treatment confirm the need for hepatitis B vaccination, particularly in view of their endemic hepatitis C infection."3.71Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination. ( Carter, H; Hailwood, C; Hanlon, C; Massarotto, A; Robinson, G, 2001)
" The descriptive analysis in heroin-assisted treatment showed a reduction in infection risk for viral hepatitis corresponding to the lower risk behaviour of patients."3.71HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. ( Blättler, R; Gutzwiller, F; Steffen, T; Zwahlen, M, 2001)
"This study evaluates the safety, tolerability, and efficacy of interferon/ribavirin combination therapy in methadone maintenance (MM) patients with active hepatitis C (HCV)."3.71Treating hepatitis C in methadone maintenance patients: an interim analysis. ( Sylvestre, DL, 2002)
" We studied the associations between retention in methadone treatment and drug use behaviors and incidence of hepatitis B and C in a cohort of IDUs in the Seattle, Washington, area."3.70Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. ( Hagan, H; Murrill, CS; Thiede, H, 2000)
"The objective of this study was to describe the incidence and prevalence of hepatitis C infection among clients of a methadone program in Queensland."3.69Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. ( Denton, M; Plant, AJ; Selvey, LA, 1997)
" Multivariate linear regression to assess correlates of HCV knowledge post-intervention revealed that optimal dosage of MMT and having had an HIV test in the past year significantly increased HCV knowledge."2.84Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia. ( Ali, SH; Altice, FL; Kamarulzaman, A; Mukherjee, TI; Pillai, V; Wickersham, JA, 2017)
" The average DAM dosage was 274."2.72Controlled trial of prescribed heroin in the treatment of opioid addiction. ( Carrasco, F; March, JC; Oviedo-Joekes, E; Perea-Milla, E, 2006)
"Methadone exposure was either decreased or unchanged when it was coadministered with weak to strong CYP3A inhibitors or a moderate CYP3A4 inducer."2.61Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned. ( Lakota, EA; Patel, V; Sahajwalla, CG; Volpe, DA; Xu, Y; Younis, IR, 2019)
"Individuals with opioid use disorders, including those on medication-assisted therapy such as methadone or buprenorphine, are a key demographic group that can benefit from HCV treatment given their high HCV prevalence; however, pharmacokinetic and pharmacodynamic drug interactions could blunt their utility."2.53Drug interactions between buprenorphine, methadone and hepatitis C therapeutics. ( Bruce, RD; Friedland, G; Ogbuagu, O, 2016)
"To describe potential drug-drug interactions in the area of HIV/hepatitis C virus (HCV) coinfection and injection drug use, including those between antiretrovirals (ARVs), direct-acting antivirals (DAAs), and opioid-agonist therapy, and to supply a practical approach to their management."2.52Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy. ( Christensen, S; Gillessen, A; Hanhoff, N; Meemken, L; Tseng, A, 2015)
"Methadone maintenance treatment (MMT) was implemented in China since 2004."2.48HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. ( Chow, EP; Liang, Y; Wang, Y; Wilson, DP; Zhang, L; Zhuang, X, 2012)
"Methadone maintenance treatment (MMT) has rapidly expanded in China, from 8 pilot sites to 696 clinics covering 27 provinces, during 2004-2010."2.48Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. ( Chow, EP; Liang, Y; Wang, Y; Wilson, DP; Zhang, L; Zhuang, X, 2012)
"The methadone maintenance treatment (MMT) program has run for more than 20 years and the public has become more tolerant of addicts."2.44Comparison of drug abuse in Germany and China. ( Fang, YX; Lu, L; Michels, II; Zhao, D; Zhao, LY, 2007)
"Methadone has significant, adverse drug-drug interactions with many antiretroviral therapeutic agents that can contribute to nonadherence and poor clinical outcomes in this high-risk population."2.43Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents. ( McCance-Katz, EF, 2005)
"We estimated the cascade of care for opioid use disorder and identified factors associated with care engagement for people with opioid use disorder (PWOUD) provincially."1.56The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada. ( Homayra, F; Hongdilokkul, N; McGowan, G; Min, JE; Nosyk, B; Pearce, LA; Piske, M; Socias, ME; Zhou, H, 2020)
"all methadone users that were positive for anti-HCV antibodies were included in the study."1.56Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa. ( Almandoz Cortajarena, E; Arenas Ruiz-Tapiador, J; Arranz Díaz, S; Bujanda, L; Castiella Eguzkiza, A; Chouza Pérez, JM; Esandi González, FJ; Gil Fernández, B; Gómez García, A; Pérez Castaño, Y; Sánchez Iturri, MJ; Sanz Largo, V; Urtasun Lugea, I, 2020)
"Opioid agonist treatment is considered important in preventing acquisition of hepatitis C virus (HCV) among people who inject drugs; however, the role of dosage in opioid agonist treatment is unclear."1.51Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs. ( Artenie, AA; Bruneau, J; Gauvin, L; Høj, S; Jacka, B; Jutras-Aswad, D; Minoyan, N; Roy, É; Zang, G, 2019)
"Methadone treatment (exposure) was self-reported and severe FI (outcome) was measured using the Household Food Security Survey Module."1.48Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. ( Cooper, C; Cox, J; Hamelin, AM; Harper, S; Klein, MB; McLinden, T; Moodie, EEM; Rossi, C; Rourke, SB; Walmsley, SL, 2018)
"Methadone status was not associated to HCV seroconversion."1.48HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination. ( Alvaro-Meca, A; Cuevas, G; Gutiérrez, J; Moreno, S; Ryan, P; Troya, J; Valencia La Rosa, J, 2018)
"A methadone maintenance treatment (MMT) program to curb the dual epidemics of HIV/AIDS and drug use has been administered by China since 2004."1.46Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program. ( He, C; Huang, W; Lan, G; Li, C; Li, M; Li, R; Liang, N; Peng, Z; Shen, Z; Tang, X; Zhong, F, 2017)
"Patients with opioid use disorders on opioid agonist therapy (OAT) have lower pain tolerance compared to controls."1.42Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. ( Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR, 2015)
"The objective was to study substance abuse, infectious disease, and patient outcomes (retention and substance abuse abstinence) over 2 decades in a large methadone maintenance treatment (MMT) facility within a tertiary-referral medical center."1.40Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel. ( Adelson, M; Peles, E; Schreiber, S, 2014)
"Methadone maintenance treatment (MMT) is a major treatment regimen for opioid dependence."1.39Hepatitis C virus infection influences the S-methadone metabolite plasma concentration. ( Chang, YS; Ho, IK; Hsu, YT; Kuo, HW; Liu, SW; Liu, YL; Tsou, HH; Wang, SC; Wu, SL, 2013)
"Methadone maintenance treatment (MMT) has been available in Guangdong province, China since 2006."1.39High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. ( Chen, W; Ling, L; Zhang, D; Zhang, L; Zou, X, 2013)
"Methadone maintenance treatment is evidenced as a successful harm reduction initiative in regard to the prevention of blood borne viruses and other injecting related harms."1.39Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'. ( Harris, M; Rhodes, T, 2013)
"Methadone maintenance treatment program patients were referred, evaluated by the internist and hepatologist in hepatitis clinic and provided HCV treatment with integration between both sites."1.38Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance. ( Beeder, AB; Dimova, R; Kreek, MJ; Marks, KM; Martinez, AD; Talal, AH; Zeremski, M, 2012)
" Clinically significant MDIs included withdrawal symptoms, which were found among MMTP patients co-administered with buprenorphine or tramadol; severe QTc prolongation effect, which might be associated with use of haloperidol or droperidol; and additive CNS and respiratory depression, which could result from use of methadone in combination with chlorpromazine or thioridazine."1.38Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. ( Lee, HY; Li, JH; Tang, HP; Wu, JS; Wu, LT; Yen, CF, 2012)
"For methadone, there was a non-significant 41 % increased advanced fibrosis risk in Whites and 51 % reduced risk in AA."1.38Finasteride and methadone use and risk of advanced hepatitis C related liver disease. ( El-Serag, HB; Hashmi, A; Kuzniarek, J; Ramsey, DJ; Tavakoli-Tabasi, S; White, DL, 2012)
"Uptake of treatment for hepatitis C virus (HCV) infection is very low particularly among people who have injected drugs."1.36Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. ( Hopwood, M; Newland, J; Rance, J; Treloar, C, 2010)
"57% had a current non-substance use psychiatric disorder."1.35Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. ( Batki, SL; Canfield, KM; Ploutz-Snyder, R; Smyth, E, 2009)
"The association between substance use, rates of completion of therapy and rates of response were assessed using multivariable regression analyses."1.35Treatment of hepatitis C infection for current or former substance abusers in a community setting. ( Daiter, J; John-Baptiste, A; Krahn, M; Lingley, M; Nedd-Roderique, T; Teplin, D; Tomlinson, G; Varenbut, M, 2009)
"Methadone maintenance therapy for the treatment of opioid dependence continues to carry a social stigma."1.34Liver transplant and hepatitis C in methadone maintenance therapy: a case report. ( Bourgeois, JA; Craemer, E; Hancock, MM; Lester, L; Prosser, CC; Ransibrahmanakul, K; Rossaro, L, 2007)
" The second part was a cross-sectional study (n = 223 doctors), which consisted of a target-week assessment of 2,694 consecutive patients to determine (a) the severity and problem profiles and treatment targets; (b) the choice and dosage scheme of the substitution drug; (c) past and current interventions, including treatment of comorbid hepatitis C; and (d) cross-sectional differences between the two drugs with regard to comorbidity, clinical course, acceptance/compliance and social integration."1.33Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study. ( Apelt, SM; Backmund, M; Bühringer, G; Gastpar, M; Gölz, J; Klotsche, J; Kraus, MR; Pittrow, D; Siegert, J; Soyka, M; Tretter, F; Wittchen, HU, 2005)
"Methadone maintenance treatment of opiate addiction is highly effective at reducing drug use, drug-related criminal activity, and risk of HIV transmission."1.33Linkage with methadone treatment upon release from incarceration: a promising opportunity. ( Clarke, J; Key, RG; McKenzie, M; Poshkus, M; Rich, JD; Shield, DC; Wolf, FA, 2005)
"Methadone is a synthetic opiate used in the treatment of opiate addiction."1.33Dental management of patients taking methadone. ( Graham, CH; Meechan, JG, 2005)
"Methadone maintenance treatment reduces drug-related-harm."1.32[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]. ( Aragonés, A; Barril, J; Esteban, J; Gimeno, C; Pellín, Mde L, 2003)

Research

Studies (231)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (4.76)18.2507
2000's84 (36.36)29.6817
2010's118 (51.08)24.3611
2020's18 (7.79)2.80

Authors

AuthorsStudies
Jiménez-Treviño, L2
Martínez-Cao, C1
Sánchez-Lasheras, F2
Iglesias, C1
Antuña, MJ1
Riera, L1
Sáiz-Martínez, PA1
Bobes, J2
Tai, CM2
Huang, CK1
Changchien, TC1
Lin, PC1
Wang, DW1
Chang, TT2
Chan, HW1
Chen, TH1
Tseng, CH2
Chen, CC1
Tsai, CT1
Sie, YT1
Yen, YC2
Yu, ML2
Lier, AJ1
Seval, N1
Vander Wyk, B1
Di Paola, A1
Springer, SA1
Khalid, K1
Ooi, YT1
Abdul Rashid, Q1
Mohammad Yusoff, MZA1
Jamaluddin, R1
Yee, WL1
Draper, B1
Myint, KT1
Min, W1
Htay, H1
O'Keefe, D1
Hellard, M2
Su, WW1
Yang, CC2
Chang, RW1
Yeh, YH1
Yen, HH1
Lee, YL1
Liu, CE1
Liang, SY1
Sung, ML1
Ko, SY1
Kuo, CY1
Chen, SL1
Yeh, YP1
Hu, TH1
Akiyama, MJ1
Columbus, D1
MacDonald, R1
Jordan, AO1
Schwartz, J1
Litwin, AH5
Eckhardt, B1
Carmody, E1
Gutiérrez-Cáceres, S1
Pedraz-Marcos, A1
Serrano-Gallardo, P1
Zhang, JY1
Li, ZB2
Zhang, L7
Wang, J2
Huang, LP2
Zhan, GL1
Li, Z1
Du, J6
Zhao, M7
Alam, F1
Wright, N1
Roberts, P1
Dhadley, S1
Townley, J1
Webster, R1
Jessop, AB2
Bass, SB3
Gutierrez, M2
Gashat, MT2
Liu, Y4
Zou, X5
Chen, W6
Gong, C2
Ling, L7
Brajuha, J1
Alhajji, M2
Burke, M1
Wellington, C1
Ventriglia, N1
Coleman, J1
D'Avanzo, P1
Piske, M1
Zhou, H1
Min, JE1
Hongdilokkul, N1
Pearce, LA1
Homayra, F1
Socias, ME2
McGowan, G1
Nosyk, B1
Ordak, M1
Nasierowski, T1
Pawlik, K1
Muszynska, E1
Bujalska-Zadrozny, M1
Pérez Castaño, Y1
Chouza Pérez, JM1
Sanz Largo, V1
Almandoz Cortajarena, E1
Gómez García, A1
Esandi González, FJ1
Castiella Eguzkiza, A1
Arranz Díaz, S1
Urtasun Lugea, I1
Sánchez Iturri, MJ1
Gil Fernández, B1
Bujanda, L1
Arenas Ruiz-Tapiador, J1
Byrne, C1
Radley, A1
Inglis, SK1
Beer, LJZ1
Palmer, N1
Pham, MD1
Healy, B1
Doyle, JS1
Donnan, P1
Dillon, JF1
Jordan, AE4
Cleland, CM2
Schackman, BR2
Wyka, K2
Perlman, DC5
Nash, D2
Sutlović, D1
Ključević, Ž1
Kuret, S1
Krekulová, L1
Vavrinčíková, L1
Huang, CL1
Tsai, IJ1
Lin, WC1
Lin, CL1
Ho, IK3
Wang, RY1
Lee, CW1
Stvilia, K1
Vephkvadze, N1
Gamkrelidze, A1
Khonelidze, I1
Getia, V1
Tsereteli, M1
Gvinjilia, L1
Kuchuloria, T1
Kilonzo, SB1
Gunda, DW1
Majinge, DC1
Jaka, H1
Manyiri, PM1
Kalokola, F1
Mtui, G1
Shao, ER1
Bakshi, FA1
Stephano, A1
Roncero, C1
Fuster, D1
Palma-Álvarez, RF1
Rodriguez-Cintas, L1
Martinez-Luna, N1
Álvarez, FJ1
Kenworthy, J1
Yi, Y1
Wright, A1
Brown, J1
Maria Madrigal, A1
Dunlop, WCN1
Birger, RB1
Le, T1
Kouyos, RD1
Grenfell, BT1
Hallett, TB1
Grassi, A1
Ballardini, G1
Mukherjee, TI1
Pillai, V1
Ali, SH1
Altice, FL4
Kamarulzaman, A1
Wickersham, JA1
Page, K3
Leeman, L1
Bishop, S1
Cano, S1
Bakhireva, LN1
Li, M1
Li, R1
Shen, Z1
Li, C1
Liang, N1
Peng, Z1
Huang, W1
He, C1
Zhong, F1
Tang, X1
Lan, G1
Zhou, ZR1
Cao, YN1
Jessop, A2
Maurer, L2
Gashat, M2
Al Hajji, M1
Xu, Y2
Xia, Y1
McLinden, T1
Moodie, EEM1
Hamelin, AM1
Harper, S1
Rossi, C1
Walmsley, SL1
Rourke, SB1
Cooper, C1
Klein, MB1
Cox, J3
Ti, L1
Wood, E4
Milloy, MJ1
Nosova, E1
DeBeck, K1
Kerr, T4
Hayashi, K1
Bauerle Bass, S1
Forry, J1
Lozano, R1
Domeque, N1
Perálvarez, C1
Torrellas, MD1
Gonzalo, C1
Azbel, L1
Wegman, MP1
Polonsky, M1
Bachireddy, C1
Meyer, J1
Shumskaya, N1
Kurmanalieva, A1
Dvoryak, S1
Valencia La Rosa, J1
Ryan, P1
Alvaro-Meca, A1
Troya, J1
Cuevas, G1
Gutiérrez, J1
Moreno, S1
Talal, AH5
McLeod, A2
Andrews, P2
Nieves-McGrath, H1
Chen, Y4
Reynolds, A1
Sylvester, C2
Dickerson, SS1
Markatou, M3
Brown, LS4
Lu, J1
Xu, X1
Zhou, Y1
Zhang, Z2
Fu, G1
Chen, G1
Younis, IR1
Lakota, EA1
Volpe, DA1
Patel, V1
Sahajwalla, CG1
Artenie, AA1
Minoyan, N1
Jacka, B1
Høj, S1
Jutras-Aswad, D1
Roy, É2
Gauvin, L1
Zang, G1
Bruneau, J1
Bair, MJ1
Huang, CF1
Yeh, ML1
Dai, CY1
Chuang, WL1
Huang, JF1
Williams, N1
Bossert, N1
Jaanimägi, U1
Roux, P3
Morel, A3
Wolfe, D1
Carrieri, P1
Ng, MH1
Chou, JY1
Chang, TJ1
Lee, PC1
Shao, WC1
Lin, TY1
Chen, VC1
Gossop, M1
Wu, Z6
Clark, N1
Bruce, RD3
Moody, DE1
Gourevitch, MN3
Friedland, GH1
Manan, MM1
Ali, SM1
Khan, MA1
Jafarian, S1
Hameed, MA1
Xia, YH2
McLaughlin, MM1
Tucker, JD2
Wang, Z2
Xiao, Z1
Mandel, JS1
Otiashvili, D1
Piralishvili, G2
Sikharulidze, Z1
Kamkamidze, G1
Poole, S1
Woody, GE1
Wu, SL2
Wang, SC2
Tsou, HH2
Kuo, HW2
Liu, SW2
Hsu, YT1
Chang, YS1
Liu, YL3
Wang, C5
Zhang, D1
Duan, S2
Han, J1
Tang, RH2
Yang, YC1
Xiang, LF1
Ye, RH1
Yang, SS1
Yang, YB1
Long, YC2
Li, GQ1
Yin, MS1
Pang, L3
Rou, KM1
Wu, ZY1
He, N1
Larios, SE1
Masson, CL2
Shopshire, MS1
Hettema, J1
McKnight, C2
Young, C2
Khalili, M1
Seewald, RM2
Min, A1
Hengl, N1
Sorensen, JL2
Des Jarlais, DC8
Wang, L1
Wei, X1
Wang, X3
Li, J5
Li, H1
Jia, W1
Gupta, S1
Iudicello, JE1
Shi, C1
Letendre, S1
Knight, A1
Riggs, PK1
Franklin, DR1
Duarte, N1
Jin, H1
Hampton Atkinson, J1
Yu, X1
Grant, I1
Heaton, RK1
Marco, A1
Gallego, C1
Caylà, JA1
Zhou, YB1
Liang, S1
Wang, QX1
Gong, YH1
Nie, SJ1
Nan, L1
Yang, AH1
Liao, Q1
Song, XX1
Jiang, QW1
Peles, E2
Schreiber, S2
Adelson, M4
Chavchanidze, M1
Gamkrelidze, I1
Nikolaishvili, N1
Phillips, KA1
Epstein, DH2
Vahabzadeh, M1
Mezghanni, M1
Lin, JL1
Preston, KL2
Nolan, S1
Dias Lima, V1
Fairbairn, N1
Montaner, J1
Grebely, J2
Lions, C2
Michel, L2
Mora, M2
Daulouède, JP1
Marcellin, F2
Spire, B3
Carrieri, PM2
Sepúlveda-Arias, JC1
Isaza, C1
Vélez, JP1
Delucchi, KL1
Tsui, JI2
Evans, JL1
Lum, PJ1
Hahn, JA1
Zhou, W2
Zhou, S2
Xie, N1
Liu, P1
Luo, L1
Peng, J1
Liu, M1
Desrosiers, A1
Schottenfeld, R1
Chawarski, MC1
Sullivan, SG2
Rou, K4
Luo, W4
Cao, X5
Yin, W3
Liu, E2
Mi, G1
Malnick, S1
Sheidvasser, V1
Basevitz, A1
Levit, S2
Lin, CK1
Hung, CC1
Peng, CY3
Chao, E1
Lee, TS2
Meemken, L1
Hanhoff, N1
Tseng, A1
Christensen, S1
Gillessen, A1
Hwang, LL1
Dai, YW1
Liu, SC1
Chen, AC1
Hsiao, CF1
Lira, MC1
Cheng, DM1
Winter, MR1
Alford, DP1
Liebschutz, JM1
Mao, J1
Edwards, RR1
Samet, JH1
Gervasoni, C1
Peri, AM1
Cattaneo, D1
Baldelli, S1
Rizzardini, G1
Milazzo, L1
Batchelder, AW1
Peyser, D1
Nahvi, S1
Arnsten, JH2
Maradan, G1
Pu, L1
Su, Y1
Wang, G1
Bai, J1
Shi, CX1
Zhao, Y1
Ogbuagu, O1
Friedland, G1
Des Jarlais, D1
Duong, HT1
Pham Minh, K1
Khuat, OH1
Nham, TT1
Arasteh, K1
Feelemyer, J1
Heckathorn, DD1
Peries, M1
Moles, JP1
Laureillard, D1
Nagot, N1
Cornford, C1
Close, H1
Zhang, JN1
Wang, YK1
Jiang, Y1
Wang, JB1
Feng, KD1
Zhang, ZM1
Zhao, Q1
Zhang, GY1
Qiu, MF1
Li, N1
Wang, XW1
Nie, YG1
Ma, YM1
Yang, WJ1
Fan, PY1
Sun, DY1
Zhu, Q1
Midgard, H1
Bramness, JG1
Skurtveit, S1
Haukeland, JW1
Dalgard, O1
Cella, E1
Kong, WH1
Liu, MQ2
Liu, PL1
Ciccozzi, M1
Salemi, M1
Chen, X1
Silva, MJ1
Pereira, C1
Loureiro, R1
Balsa, C1
Lopes, P1
Água-Doce, I1
Belo, E1
Martins, HC1
Coutinho, R2
Pádua, E1
Brown, JL1
Gause, NK1
Lewis, D1
Winhusen, T1
Wurst, FM1
Dürsteler-MacFarland, KM1
Auwaerter, V1
Ergovic, S1
Thon, N1
Yegles, M1
Halter, C1
Weinmann, W1
Wiesbeck, GA1
Treloar, C3
Holt, M1
Todadze, K1
Lezhava, G1
Nyamathi, A1
de Castro, V1
McNeese-Smith, D1
Nyamathi, K1
Shoptaw, S1
Marfisee, M1
Khalilifard, F1
Cohen, A1
Batki, SL2
Canfield, KM2
Smyth, E2
Ploutz-Snyder, R1
Morissette, C1
De, P2
Tremblay, C1
Allard, R1
Graves, L1
Stephenson, R1
John-Baptiste, A1
Varenbut, M1
Lingley, M1
Nedd-Roderique, T1
Teplin, D1
Tomlinson, G1
Daiter, J1
Krahn, M1
Ryder, N1
Cullen, W4
Barry, J1
Bury, G4
Keenan, E1
Smyth, BP1
Pei, DE1
Peng, JS1
Liu, AJ1
An, EI1
Murray, HG1
Tetstall, E1
Leroi, MJ1
Nanan, RK1
Petoumenos, K1
Matthews, GV1
Haber, P2
Marks, P1
Lloyd, AR1
Kaldor, JM1
Dore, GJ4
Cohen-Moreno, R2
Schiff, M2
Levitt, S1
Bar-Hamburger, R1
Strauss, S1
Neumark, Y2
Newland, J2
Rance, J2
Hopwood, M2
Dolan, K4
Teutsch, S1
Scheuer, N1
Levy, M1
Rawlinson, W1
Kaldor, J2
Lloyd, A1
Curth, NK1
Hansson, LN1
Storm, F1
Lazarus, JV1
Lau, EM1
McCaughan, G1
Torzillo, PJ1
Vickerman, P2
Martin, N1
Hickman, M2
Hao, Y1
Sun, X1
Gong, X1
Li, F1
Martinez, AD1
Dimova, R1
Marks, KM1
Beeder, AB1
Zeremski, M2
Kreek, MJ3
Taylor, LE1
Bowman, SE1
Chapman, S1
Zaller, N1
Stein, MD1
Cioe, PA1
Maynard, MA1
McGovern, BH1
Salimi, S2
Nassirimanesh, B2
Mohsenifar, S2
Mokri, A2
Shen, HC1
Wu, WH1
Huang, CW1
Yen, MY3
Wang, BE1
Chuang, P3
Shih, CY1
Chou, YC1
Chan, DP1
Lee, SS2
Lee, KC2
Turner, KM1
Hutchinson, S1
Hope, V1
Craine, N1
Palmateer, N1
May, M1
Taylor, A2
De Angelis, D1
Cameron, S2
Parry, J1
Lyons, M1
Goldberg, D1
Allen, E1
Saiz, PA1
García-Portilla, MP1
Díaz-Mesa, EM1
Burón, P1
Casares, MJ1
Marina, P1
Gutiérrez, E1
Rados, V1
Allsop, D1
Sharma, A1
Cohen, HW1
Freeman, R1
Santoro, N1
Schoenbaum, EE1
Bini, EJ1
Kritz, S2
Robinson, J1
Calsyn, D1
Alderson, D1
Tracy, K1
McAuliffe, P1
Smith, C1
Rotrosen, J1
Berg, KM1
Li, X1
Hidalgo, J1
Deren, S1
Kang, SY1
Mino, M1
Hser, Y1
Chang, YJ1
Evans, E1
Morse, DS1
Williams, GC1
Eiserman, J1
Acosta, A1
Gote, C1
Lim, JK1
Xie, B1
Dimova, RB1
Seewald, R1
Peterson, RH1
Lee, HY1
Li, JH1
Wu, LT1
Wu, JS1
Yen, CF1
Tang, HP1
White, DL1
Hashmi, A1
Ramsey, DJ1
Kuzniarek, J1
Tavakoli-Tabasi, S1
El-Serag, HB1
Zhuang, X2
Liang, Y2
Chow, EP2
Wang, Y2
Wilson, DP2
Yen, YF2
Rodwell, TC1
Hsu, YH1
Li, LH2
Su, LW2
Yang, YH1
Jiang, XR2
Fang, YC1
Garfein, RS1
Allen, EJ1
Palmateer, NE1
Hutchinson, SJ1
Goldberg, DJ1
Wu, F1
Jiang, H1
Zhang, R1
Hser, YI1
Tan, L1
Li, Y1
Zhang, Y1
Zhou, D1
Liu, T1
Hao, W1
Li, D1
Chu, P1
Yang, Y1
Li, S1
Ruan, Y1
Liu, Z1
Lu, L2
Jia, Z1
McNicholas, LF1
Holbrook, AM1
O'Grady, KE1
Jones, HE1
Coyle, MG1
Martin, PR1
Heil, SH1
Stine, SM1
Kaltenbach, K1
Poundstone, KE1
Harris, M1
Rhodes, T1
Deng, CY1
Piccolo, P1
Borg, L1
Lin, A1
Melia, D1
Ho, A1
Sibbald, B1
Clarke, SM2
Mulcahy, FM2
Esteban, J1
Gimeno, C1
Aragonés, A1
Barril, J1
Pellín, Mde L1
Wilczek, H1
Urbánek, P1
Strauss, SM5
Astone, J1
Vassilev, ZP1
Hagan, H6
Perry, M1
Chew-Graham, C1
Di Martini, A1
Weinrieb, R1
Weinrieb, RM1
Barnett, R1
Lynch, KG1
DePiano, M1
Atanda, A1
Olthoff, KM1
Astone, JM3
Jarlais, DD1
Haig, T1
Sheerin, IG1
Green, FT1
Sellman, JD1
Baklan, Z1
Gorisek, JR1
Poljak, M1
Pisec, A1
Lançon, C1
Jaquet, I1
Labrune, N1
Bartolo, K1
De Stopeleire, C1
Auquier, P1
Hallinan, R3
Byrne, A3
Amin, J2
Sylvestre, DL3
Soloway, I1
Backmund, M2
Reimer, J1
Meyer, K1
Gerlach, JT1
Zachoval, R1
Walley, AY1
White, MC1
Kushel, MB1
Song, YS1
Tulsky, JP1
Kelly, Y3
Stanley, J3
Langton, D3
Dolan, KA1
Shearer, J2
White, B1
Zhou, J1
Wodak, AD1
Wittchen, HU1
Apelt, SM1
Bühringer, G1
Gastpar, M1
Gölz, J1
Kraus, MR1
Tretter, F1
Klotsche, J1
Siegert, J1
Pittrow, D1
Soyka, M1
Farley, J1
Vasdev, S1
Fischer, B1
Haydon, E1
Rehm, J1
Farley, TA1
Clements, BJ1
Rich, JD1
McKenzie, M1
Shield, DC1
Wolf, FA1
Key, RG1
Poshkus, M1
Clarke, J1
Graham, CH1
Meechan, JG1
McCance-Katz, EF1
Warren, E1
Viney, R1
Shanahan, M1
Wodak, A1
Palepu, A1
Tyndall, MW1
Joy, R1
Press, N1
Hogg, RS1
Montaner, JS1
Chu, M1
Madray, C1
Lu, GH1
Wang, QY1
Xu, H1
Zhu, M1
McCoy, CB1
Gelkopf, M2
Weizman, T1
Melamed, Y1
Bleich, A2
March, JC1
Oviedo-Joekes, E1
Perea-Milla, E1
Carrasco, F1
Préau, M1
Protopopescu, C1
Dellamonica, P1
Poizot-Martin, I1
Villes, V1
Carrieri, MP1
Staines, A1
Jürgens, R1
Betteridge, G1
Bonnet, N1
Munoz-Plaza, CE1
Astone-Twerwll, JM1
Hancock, MM1
Prosser, CC1
Ransibrahmanakul, K1
Lester, L1
Craemer, E1
Bourgeois, JA1
Rossaro, L1
Bannan, N1
Rooney, S1
O'connor, J1
Semba, RD1
Ricketts, EP1
Mehta, SF1
Kirk, GD1
Latkin, C1
Galai, N1
Vlahov, D1
Okon, T1
Cofrancesco, J1
Brown, TT1
Luo, RF1
John, M1
Stewart, KJ1
Dobs, AS1
Miller, CL1
Strathdee, SA1
Li, K1
van Beek, I1
Van Den Berg, C1
Smit, C1
Van Brussel, G1
Prins, M1
Novick, DM1
Boivin, JF1
Platt, RW1
Jolly, AM1
Michels, II1
Fang, YX1
Zhao, D1
Zhao, LY1
Pelet, A1
Doll, S1
Huissoud, T1
Resplendino, J1
Besson, J1
Favrat, B1
Willner-Reid, J1
Belendiuk, KA1
Schmittner, J1
Lim, WW1
Aitken, CK1
Higgs, PG1
Hellard, ME1
Chetwynd, J1
Brunton, C1
Blank, M1
Plumridge, E1
Baldwin, D1
Crofts, N2
Hopper, JL1
Bowden, DS1
Breschkin, AM1
Milner, R1
Locarnini, SA1
Van Ameijden, EJ1
Van den Hoek, JA1
Mientjes, GH1
Coutinho, RA1
Selvey, LA1
Denton, M1
Plant, AJ1
Nigro, L1
Oman, K1
Stevenson, E1
Sherman, J1
Lozano Polo, JL1
Gutiérrez Mora, E1
Martínez Pérez, V1
Santamaría Gutiérrez, J1
Vada Sánchez, J1
Vallejo Correas, JA1
Salter, A1
Solomon, PJ1
Stein, GL1
Fleischman, AR1
Broers, B1
Junet, C1
Bourquin, M1
Déglon, JJ2
Perrin, L1
Hirschel, B2
Schmidt, V1
Hayward, R1
Bodner, G1
Ebert, FW1
Thiede, H1
Murrill, CS1
Zylberberg, H1
Fontaine, H1
Corréas, JM1
Carnot, F1
Bréchot, C1
Pol, S1
Cayol, V1
Corcos, M1
Clervoy, P1
Speranza, M1
Stephenson, J1
Koch, M1
Banys, P1
McCarthy, JJ1
Flynn, N1
Tennant, F1
Carter, H1
Robinson, G1
Hanlon, C1
Hailwood, C1
Massarotto, A1
Ladewig, D1
Steffen, T1
Blättler, R1
Gutzwiller, F1
Zwahlen, M1
Lines, R1
Chamot, E1
de Saussure, P1
Perrin, LH1

Clinical Trials (17)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City Jails[NCT04036760]105 participants (Actual)Observational2015-05-31Completed
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China[NCT01647191]240 participants (Actual)Interventional2011-07-01Completed
Reaching mEthadone Users Attending Community pHarmacies With HCV[NCT03935906]210 participants (Actual)Interventional2019-10-08Completed
Targeted Focus Groups Discussions (FGDs) and Cross-sectional Questionnaire to Address Questions Regarding Telemedicine Concept and Knowledge, and Social Media Usage Among People Who Inject Drugs (PWID) in Greece[NCT05794984]220 participants (Anticipated)Observational2023-05-01Active, not recruiting
Suboxone and Methadone for HIV Risk Reduction in Subutex Injectors[NCT01131273]Phase 368 participants (Actual)Interventional2010-06-30Completed
Initialization of Methadone in Primary Care; a Randomized Intervention Research for Preventing HCV Transmission Practices. ANRS Methaville[NCT00657397]Phase 3197 participants (Actual)Interventional2009-01-31Completed
A Prospective, Single Arm, Open-label 96 Week Observational Trial of the Tolerability, Adherence and Efficacy of a Dolutegravir/Abacavir/Lamivudine Single Tablet Regimen in HIV-1 Antibody Positive People Living With HIV With a History of Injection Drug Us[NCT02659761]Phase 450 participants (Anticipated)Interventional2016-11-30Recruiting
[NCT01059747]500 participants (Anticipated)Observational2008-12-31Recruiting
Feasibility of an Interventional Project to Reduce HIV Incidence Among People Who Inject Drugs in Haiphong, Viet Nam[NCT02573948]603 participants (Actual)Observational2014-09-30Completed
DRIVE (DRug Use and Infections in ViEtnam) Project : Ending the HIV Epidemic Among Persons Who Inject Drugs in Hai Phong, Viet Nam[NCT03526939]5,546 participants (Actual)Observational2016-10-17Completed
Towards Ending HCV Infection Among Active Drug Users: a Community-based Intervention in Montpellier.[NCT04008927]554 participants (Actual)Interventional2020-09-18Completed
Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam[NCT03537196]Phase 4979 participants (Actual)Interventional2018-11-13Completed
Directly Observed Hepatitis C Treatment in Methadone Clinics[NCT01442311]80 participants (Actual)Interventional2007-10-31Completed
Maternal Opioid Treatment: Human Experimental Research[NCT00271219]Phase 3175 participants (Actual)Interventional2005-07-31Completed
A Prospective Cohort Study Comparing the Effectiveness of Zepatier for the Treatment of Hepatitis C in an Academic Center Population to People Who Inject Drugs (PWIDs) in a Safety Net Clinic Setting Engaged in Either a Medication Assisted Therapy (MAT) or[NCT03093415]Phase 4100 participants (Actual)Interventional2017-05-30Completed
Oral Ketamine for Control of Chronic Pain in Children[NCT01369680]Phase 112 participants (Actual)Interventional2011-05-31Completed
[NCT00292123]Phase 1200 participants (Actual)Interventional1999-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

HCV Seroconversion

Number of new HCV infection among HCV negative (at RDS) cohort participants over 1 year period (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
HCV Negative Cohort Participants18

HIV Incidence

HIV incidence was calculated by 100person/year. With zero conversion, we choose 2.5% unilateral confidence interval. (NCT02573948)
Timeframe: 52 weeks

Interventioninfections per 100 person-years (Number)
HIV Negative Cohort Participants0

HIV Seroconversion

Number of new HIV infection among HIV negative (at RDS) cohort participants over 1 year period. (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
HIV Negative Cohort Participants0

Incidence of HCV Infection

The HCV incidence was calculated by 100person/year (NCT02573948)
Timeframe: 52 weeks

Interventioninfections per 100 person-years (Number)
HCV Negative Cohort Participants19.4

Number of Cohort Participants Attending the Last Follow-up Visit at W52

Number of participants who were followed up and not lost to follow-up after enrolment into cohort. (NCT02573948)
Timeframe: 52 weeks

InterventionParticipants (Count of Participants)
PWID Cohort194

Child's Head Circumference Measurement (Measured at Birth)

(NCT00271219)
Timeframe: birth

Interventioncm (Mean)
A Methadone33.0
B Buprenorphine33.8

Child's Length of Hospital Stay

(NCT00271219)
Timeframe: delivery until hospital discharge (min=2 days, max=79 days)

Interventiondays (Mean)
A Methadone17.5
B Buprenorphine10.0

Child's Peak Daily Total NAS Score

NAS was measured with the MOTHER NAS scale, which includes 28 items, 19 of which are used for scoring and medication decisions. Scores can range from 0 to 42, with higher scores indicating more severe withdrawal. (NCT00271219)
Timeframe: minimum twice daily from birth until NAS no longer measured (min=10 days)

InterventionScore on the scale (Mean)
A Methadone12.8
B Buprenorphine11.0

Mother's HIV Risk Behaviors (Measured Monthly by Risk Behavior Assessment)

(NCT00271219)
Timeframe: monthly from study entry until discontinuation or delivery (min=29 days, max=239 days)

Interventionpercentage of HIV risk behaviors (Number)
A MethadoneNA
B BuprenorphineNA

Mother's Measures of Dose Adequacy and Acceptance Over Time (Measured Weekly by Dose Adequacy Measure)

Pregnant women maintained on an opioid agonist medication may require upward adjustment to their medication during the course of pregnant. The Dose Adequacy Measure represented a recordation of dosing adjustments during the course of the study. (NCT00271219)
Timeframe: from study entry until discontinuation or delivery (min=29 days, max=239 days)

Interventiondose increase per trimester (Number)
A MethadoneNA
B BuprenorphineNA

Mother's Psychosocial Functioning at Delivery as Measured by the Addiction Severity Index Psychosocial Index Score

The Addiction Severity Index is a structured clinical interview that assesses problem severity in 7 areas of functioning: alcohol use, drug use, medical, legal, employment, psychosocial, and psychiatric status. Each area of functioning yields a composite scale score between 0 and 1, with higher scores indicating greater problem severity in that area. Only the psychosocial index was examined in this study. (NCT00271219)
Timeframe: at delivery

InterventionScore on the scale (Mean)
Methadone.014
Buprenorphine.088

Mother's Self-report of Drug Use (Measured Monthly by Time Line Follow Back)

(NCT00271219)
Timeframe: monthly from study entry until discontinuation or delivery (min=29 days, max=239 days)

Interventionpercentage of drug use (Number)
A MethadoneNA
B BuprenorphineNA

Number of Children Requiring Treatment for Neonatal Abstinence Signs (NAS)

Neonatal abstinence syndrome (NAS) characterized by hyperirritability of the central nervous system and dysfunction in the autonomic nervous system, gastrointestinal tract, and respiratory system.11 When left untreated, NAS can result in serious illness (e.g., diarrhea, feeding difficulties, weight loss, and seizures) and death. (NCT00271219)
Timeframe: From birth until hospital discharge (min=4 days, max=10, depending on site)

Interventionparticipants (Number)
A Methadone41
B Buprenorphine27

Total Amount of Morphine Sulfate That a Neonate Receives to Treat NAS

Total amount in mg (NCT00271219)
Timeframe: Start of NAS treatment until discontinuation of NAS treatment (min=0 days, max=76 days)

Interventionmg (Mean)
A Methadone10.4
B Buprenorphine1.1

Neurocognitive Effect

"Baseline neurocognitive testing will be done before study drug is given. Subjects will be reassessed for any changes in neurocognitive scores at end of dosing (week 2) and at three weeks off study drug (week 14). Significant changes were measured at week 14 compared to baseline. Week 2 was measured to inform future studies.~The neurocognitive scores are standardized scores with a mean of 100; low scores correlate with low neurocognitive function, while high scores correlate with high function. A significant change is defined as greater than or equal to 10% decrease in scores." (NCT01369680)
Timeframe: At 14 weeks

Interventionparticipants (Number)
Ketamine 0.25 mg/kg/Dose0
Ketamine 0.5 mg/kg/Dose0
Ketamine 1 mg/kg/Dose0
Ketamine 1.5 mg/kg/Dose0

Norketamine Cmax (Measured in ng/mL).

Pharmacokinetic testing will be done during chronic ketamine administration on subjects consenting to additional testing one week into study drug administration. This is to further describe the activity of ketamine in the blood of children when administered chronically and to enable comparison of any clinical effect or toxicity with steady state levels of ketamine in children. (NCT01369680)
Timeframe: At week 1

Interventionng/mL (Mean)
Ketamine 0.25 mg/kg/Dose37.5
Ketamine 0.5 mg/kg/Dose135
Ketamine 1 mg/kg/Dose250

Number of Participants Tolerating Dose

According to CTCae any dose causing grade 2 or worse toxicity will be an untolerated dose. Tolerability is defined as ability to take the medication for 2 weeks without having a grade 2 or worse toxicity. (NCT01369680)
Timeframe: Up to 2 weeks

Interventionparticipants (Number)
Ketamine 0.25 mg/kg/Dose3
Ketamine 0.5 mg/kg/Dose3
Ketamine 1 mg/kg/Dose3
Ketamine 1.5 mg/kg/Dose1

Pain Control

"Subjects will be assessed for clinically significant change in pain scores during and after study drug administration. Significant change in pain scores were determined at week 2, though week 14 scores were collected as well.~Participants with a 2 point (or greater) decrease in pain scores compared to baseline were considered to have responded. The NRS scale was used, the scale ranges from 0-10, with 10 being the most pain." (NCT01369680)
Timeframe: Week 2

Interventionparticipants (Number)
Ketamine 0.25 mg/kg/Dose3
Ketamine 0.5 mg/kg/Dose0
Ketamine 1 mg/kg/Dose2
Ketamine 1.5 mg/kg/Dose0

Reviews

15 reviews available for methadone and Hepatitis C

ArticleYear
Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:8

    Topics: Analgesics, Opioid; Antiviral Agents; Cytochrome P-450 CYP2B6; Drug Interactions; Hepatitis C; HIV I

2019
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
    Expert review of clinical pharmacology, 2013, Volume: 6, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Anti-Retroviral Agents; Buprenorphine; Drug

2013
Review on the demographic and social impact of methadone-medication therapy on Malaysian patients.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:4

    Topics: Adult; Cross-Sectional Studies; Employment; Female; Hepatitis C; HIV Infections; Humans; Malaysia; M

2013
Drug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:7

    Topics: Analgesics, Opioid; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C; HIV Infections; H

2015
Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.
    Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:7

    Topics: Animals; Antiviral Agents; Buprenorphine; Drug Interactions; Hepatitis C; Humans; Methadone; Opioid-

2016
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:11

    Topics: Adult; Disease Transmission, Infectious; Epidemiologic Methods; Female; Harm Reduction; Hepatitis C;

2011
HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    BMC infectious diseases, 2012, Jun-08, Volume: 12

    Topics: China; Coinfection; Hepatitis C; HIV Infections; Methadone; Opiate Substitution Treatment; Prevalenc

2012
Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Drug and alcohol dependence, 2012, Dec-01, Volume: 126, Issue:3

    Topics: Adult; Age Factors; China; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Narcotics;

2012
Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40 Suppl 5

    Topics: Adult; Delivery of Health Care; Female; Genotype; Germany; Health Planning Guidelines; Hepatitis C;

2005
Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-01, Volume: 41 Suppl 1

    Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; Drug Evaluation; Drug

2005
Prisoners who inject drugs: public health and human rights imperatives.
    Health and human rights, 2005, Volume: 8, Issue:2

    Topics: AIDS Serodiagnosis; Global Health; Hepatitis C; HIV Infections; Human Rights; Humans; International

2005
Ketamine: an introduction for the pain and palliative medicine physician.
    Pain physician, 2007, Volume: 10, Issue:3

    Topics: Adult; Amines; Analgesics; Analgesics, Opioid; Central Nervous System; Cryoglobulinemia; Cyclohexane

2007
Comparison of drug abuse in Germany and China.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; China; Drug and Narcotic Control; Geography; Germany; Hepatitis

2007
Antiretroviral therapy for drug users.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:10

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Drug Therapy, Combination

2000
[Pregnancy and drug abuse: current situation and therapeutic strategies].
    Annales de medecine interne, 2000, Volume: 151 Suppl B

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Female; Fetal Growth Retardation; Hepatit

2000

Trials

22 trials available for methadone and Hepatitis C

ArticleYear
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
    Journal of substance abuse treatment, 2022, Volume: 142

    Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Hepatitis C; HIV Infections; Humans;

2022
Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial.
    BMC infectious diseases, 2019, Aug-08, Volume: 19, Issue:1

    Topics: Adult; Community Health Services; Continuity of Patient Care; Female; Hepatitis C; Hispanic or Latin

2019
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
    BMC infectious diseases, 2019, Sep-05, Volume: 19, Issue:1

    Topics: Adult; Awareness; China; Cluster Analysis; Drug Users; Efficiency, Organizational; Female; Health Kn

2019
    BMJ open, 2020, 08-30, Volume: 10, Issue:8

    Topics: Antiviral Agents; Australasia; Australia; Drug Users; Europe; Hepacivirus; Hepatitis C; Hepatitis C,

2020
Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.
    The International journal on drug policy, 2017, Volume: 47

    Topics: Adult; Female; Health Education; Health Knowledge, Attitudes, Practice; Hepatitis C; Humans; Malaysi

2017
The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
    PloS one, 2018, Volume: 13, Issue:3

    Topics: Adolescent; Adult; British Columbia; Delivery of Health Care; Female; Hepatitis C; Humans; Male; Met

2018
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Drug and alcohol dependence, 2013, Dec-01, Volume: 133, Issue:2

    Topics: Adult; Buprenorphine; Female; Georgia (Republic); Hepatitis C; HIV Infections; Humans; Male; Methado

2013
Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.
    Journal of substance abuse treatment, 2014, Volume: 46, Issue:4

    Topics: Adult; Counseling; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Hepatitis A; He

2014
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.
    Substance abuse treatment, prevention, and policy, 2014, Sep-10, Volume: 9

    Topics: Adult; Confidence Intervals; Feasibility Studies; Female; Hepatitis C; Humans; Logistic Models; Male

2014
Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions.
    Journal of addictive diseases, 2014, Volume: 33, Issue:4

    Topics: Adult; Aged; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Male; Methadone; Middle Aged; Ne

2014
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).
    Comprehensive psychiatry, 2015, Volume: 62

    Topics: Adult; Analgesics, Opioid; Female; Food Assistance; Hepacivirus; Hepatitis C; Humans; Male; Methadon

2015
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
    Drug and alcohol dependence, 2010, Mar-01, Volume: 107, Issue:2-3

    Topics: Acute Disease; Adult; Antiviral Agents; Australia; Cohort Studies; Female; Hepacivirus; Hepatitis C;

2010
Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
    BMC infectious diseases, 2011, Nov-12, Volume: 11

    Topics: Adult; Antiviral Agents; Directly Observed Therapy; Drug Therapy, Combination; Female; Hepatitis C;

2011
Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:3

    Topics: Adult; Antiviral Agents; Directly Observed Therapy; Female; Hepacivirus; Hepatitis C; Humans; Interf

2012
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.
    Addiction (Abingdon, England), 2012, Volume: 107 Suppl 1

    Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Female; gamma-Glutamyltransferase; Hepatitis C

2012
Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison.
    Canadian HIV/AIDS policy & law review, 2003, Volume: 8, Issue:3

    Topics: Canada; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Incidence; Methadone; New South Wale

2003
Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Addiction (Abingdon, England), 2005, Volume: 100, Issue:6

    Topics: Adult; Cohort Studies; Communicable Diseases; Follow-Up Studies; Hepatitis C; Heroin Dependence; HIV

2005
Value for money in drug treatment: economic evaluation of prison methadone.
    Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2

    Topics: Costs and Cost Analysis; Health Expenditures; Hepatitis C; Heroin Dependence; HIV Infections; Humans

2006
Controlled trial of prescribed heroin in the treatment of opioid addiction.
    Journal of substance abuse treatment, 2006, Volume: 31, Issue:2

    Topics: Adult; Counseling; Drug Administration Schedule; Drug Prescriptions; Female; Health Status; Hepatiti

2006
Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2006, Volume: 56, Issue:532

    Topics: Adult; Cluster Analysis; Family Practice; Female; Follow-Up Studies; Hepatitis C; Humans; Male; Meth

2006
Adherence and retention of female injection drug users in a phase III clinical trial in inner city Baltimore.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:1

    Topics: Adult; Baltimore; Demography; Female; Follow-Up Studies; Hepatitis C; HIV Infections; Humans; Methad

2007
[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
    Revista clinica espanola, 1997, Volume: 197, Issue:7

    Topics: Adult; Female; Hepatitis C; Humans; Liver; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antago

1997

Other Studies

194 other studies available for methadone and Hepatitis C

ArticleYear
A 35-year follow-up study of patients admitted to methadone treatment between 1982-1984 in Asturias, Spain.
    Adicciones, 2023, Sep-01, Volume: 35, Issue:3

    Topics: Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Heroin; Heroin Dependence; HIV Seropositivity;

2023
Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
    Viruses, 2022, 07-27, Volume: 14, Issue:8

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Hepacivirus; Hepatitis C; Hepatitis C, Chronic;

2022
Methadone Maintenance Treatment for Opioid Dependents: a Retrospective Study.
    East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 2022, Volume: 32, Issue:3

    Topics: Adult; Analgesics, Opioid; Hepatitis C; Heroin; Humans; Illicit Drugs; Methadone; Methamphetamine; M

2022
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
    Harm reduction journal, 2022, 09-29, Volume: 19, Issue:1

    Topics: Drug Users; Hepatitis C; HIV Infections; Humans; Methadone; Myanmar; Substance Abuse, Intravenous; S

2022
A new collaborative care approach toward hepatitis C elimination in marginalized populations.
    Journal of infection and public health, 2023, Volume: 16, Issue:8

    Topics: Antiviral Agents; Hepacivirus; Hepatitis C; HIV Infections; Humans; Methadone; Substance Abuse, Intr

2023
[Aging in a methadone maintenance program. A perspective from the framework of social determinants of health].
    Revista espanola de salud publica, 2019, Aug-26, Volume: 93

    Topics: Adult; Age of Onset; Aging; Comorbidity; Female; Hepatitis C; HIV Infections; Humans; Life Expectanc

2019
Optimising opioid substitution therapy in the prison environment.
    International journal of prisoner health, 2019, 12-05, Volume: 15, Issue:4

    Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Dr

2019
Perceptions of Barriers and Benefits of HCV Treatment and Correlates to Treatment Intention in Methadone Patients.
    Journal of health care for the poor and underserved, 2019, Volume: 30, Issue:4

    Topics: Adaptation, Psychological; Adult; Aged; Attitude to Health; Female; Hepatitis C; Humans; Intention;

2019
Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study.
    International journal of environmental research and public health, 2019, 11-12, Volume: 16, Issue:22

    Topics: Adult; Antiviral Agents; China; Cross-Sectional Studies; Female; Hepacivirus; Hepatitis C; Humans; M

2019
"Take Charge, Get Cured": Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy.
    Journal of substance abuse treatment, 2020, Volume: 109

    Topics: Decision Support Techniques; Female; Health Knowledge, Attitudes, Practice; Hepacivirus; Hepatitis C

2020
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
    Addiction (Abingdon, England), 2020, Volume: 115, Issue:8

    Topics: Adult; Analgesics, Opioid; British Columbia; Buprenorphine; Female; Hepatitis C; Humans; Ill-Housed

2020
Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010-19.
    International journal of psychiatry in clinical practice, 2020, Volume: 24, Issue:3

    Topics: Adult; Amphetamine-Related Disorders; Comorbidity; Cross-Sectional Studies; Female; Hepatitis C; Her

2020
Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa.
    Revista espanola de enfermedades digestivas, 2020, Volume: 112, Issue:7

    Topics: Antiviral Agents; Drug Users; Hepacivirus; Hepatitis C; Humans; Methadone; Opiate Substitution Treat

2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
    The Journal of infectious diseases, 2020, 09-02, Volume: 222, Issue:Suppl 5

    Topics: Adolescent; Adult; Aged; Continuity of Patient Care; Endemic Diseases; Female; Health Services Needs

2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    The Journal of infectious diseases, 2020, 09-02, Volume: 222, Issue:Suppl 5

    Topics: Adolescent; Adult; Aged; Female; Hepacivirus; Hepatitis C; Humans; Incidence; Male; Methadone; Middl

2020
ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients.
    Arhiv za higijenu rada i toksikologiju, 2020, Dec-31, Volume: 71, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Hepa

2020
Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program.
    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2021,Spring, Volume: 70, Issue:1

    Topics: Antiviral Agents; Czech Republic; Hepatitis C; Humans; Methadone; Opiate Substitution Treatment; Pha

2021
Reduced mortality in patients with extended duration of methadone maintenance treatment: a five-year retrospective nationwide study.
    Psychological medicine, 2023, Volume: 53, Issue:3

    Topics: Cohort Studies; Female; Hepatitis C; Humans; Male; Methadone; Opiate Substitution Treatment; Retrosp

2023
Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
    Public health, 2021, Volume: 195

    Topics: Antiviral Agents; Georgia; Georgia (Republic); Hepatitis C; Humans; Methadone; Retrospective Studies

2021
Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study.
    BMC infectious diseases, 2021, Jul-21, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Cross-Sectional Studies; Drug Users; Female; Health K

2021
HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
    AIDS care, 2017, Volume: 29, Issue:12

    Topics: Adult; Analgesics, Opioid; Anti-Retroviral Agents; Coinfection; Comorbidity; Dose-Response Relations

2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Journal of medical economics, 2017, Volume: 20, Issue:7

    Topics: Buprenorphine; Cost-Benefit Analysis; Crime; Health Services; Hepatitis C; HIV Infections; Humans; M

2017
The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
    PloS one, 2017, Volume: 12, Issue:5

    Topics: Anti-Retroviral Agents; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Likelihood Functio

2017
Hepatitis C in injection drug users: It is time to treat.
    World journal of gastroenterology, 2017, May-28, Volume: 23, Issue:20

    Topics: Antiviral Agents; Buprenorphine; Drug Users; Hepatitis C; Humans; Interdisciplinary Communication; L

2017
Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.
    Maternal and child health journal, 2017, Volume: 21, Issue:9

    Topics: Adult; Analgesics, Opioid; Female; Hepacivirus; Hepatitis C; Humans; Mass Screening; Methadone; Mexi

2017
Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    BMJ open, 2017, Jul-13, Volume: 7, Issue:7

    Topics: Adolescent; Adult; China; Coinfection; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C Ant

2017
Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.
    BMC public health, 2017, 09-30, Volume: 17, Issue:1

    Topics: Adult; China; Cohort Studies; Coinfection; Drug Users; Female; Hepatitis C; HIV Infections; Humans;

2017
Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.
    Harm reduction journal, 2017, 11-02, Volume: 14, Issue:1

    Topics: Adult; Alcoholism; Analgesics, Opioid; China; Drug Users; Female; Health Knowledge, Attitudes, Pract

2017
Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development.
    Journal of health communication, 2018, Volume: 23, Issue:1

    Topics: Adult; Aged; Female; Health Care Surveys; Health Services Accessibility; Hepatitis C; Humans; Male;

2018
Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.
    Substance abuse treatment, prevention, and policy, 2018, 01-10, Volume: 13, Issue:1

    Topics: China; Cross-Sectional Studies; Hepatitis C; HIV Infections; Humans; Methadone; Models, Biological;

2018
Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
    Drug and alcohol dependence, 2018, 04-01, Volume: 185

    Topics: Adult; Analgesics, Opioid; Canada; Cohort Studies; Coinfection; Female; Food Supply; Hepatitis C; HI

2018
Take Charge, Get Cured: The development and user testing of a culturally targeted mHealth decision tool on HCV treatment initiation for methadone patients.
    Patient education and counseling, 2018, Volume: 101, Issue:11

    Topics: Adult; Decision Making; Drug Users; Hepatitis C; Humans; Male; Methadone; Middle Aged; Opiate Substi

2018
Mortality rate in patients on methadone treatment and infected with the human immunodeficiency virus and/or the hepatitis C virus.
    Adicciones, 2019, Jan-01, Volume: 31, Issue:1

    Topics: Adult; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middle Aged;

2019
Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    International journal of prisoner health, 2018, 09-10, Volume: 14, Issue:3

    Topics: Adult; Female; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Kyrgyzstan; Male;

2018
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
    PloS one, 2018, Volume: 13, Issue:10

    Topics: Adult; Cohort Studies; Female; Harm Reduction; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Hum

2018
Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program.
    Telemedicine journal and e-health : the official journal of the American Telemedicine Association, 2019, Volume: 25, Issue:9

    Topics: Adult; Antiviral Agents; Combined Modality Therapy; Disease Management; Female; Hepatitis C; Humans;

2019
Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 07-02, Volume: 69, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Antiviral Agents; Disease Management; Female; Hepatitis C; Humans;

2019
Hepatitis C virus genotype diversity and distribution among methadone maintenance treatment patients in Jiangsu, China.
    Drug and alcohol dependence, 2019, 01-01, Volume: 194

    Topics: Adult; China; Female; Genetic Variation; Genotype; Hepacivirus; Hepatitis C; Hepatitis C Antibodies;

2019
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, 04-29, Volume: 191, Issue:17

    Topics: Adult; Buprenorphine; Cohort Studies; Disease Transmission, Infectious; Drug Users; Female; Hepatiti

2019
Integrated care for methadone maintenance patients with hepatitis C virus infection.
    The Kaohsiung journal of medical sciences, 2019, Volume: 35, Issue:8

    Topics: Adult; Antiviral Agents; Cohort Studies; Delivery of Health Care, Integrated; Female; Follow-Up Stud

2019
Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection.
    Journal of substance abuse treatment, 2019, Volume: 102

    Topics: Adult; Cross-Sectional Studies; Female; Hepatitis C; Humans; Male; Methadone; Middle Aged; Opiate Su

2019
Methadone in primary care in France: Using evidence for action against hepatitis C.
    The International journal on drug policy, 2019, Volume: 71

    Topics: France; Hepatitis C; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pri

2019
High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
    Addictive behaviors, 2013, Volume: 38, Issue:4

    Topics: Adult; Analgesics, Opioid; Criminals; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; He

2013
Scaling up opioid dependence treatment in low- and middle-income settings.
    Bulletin of the World Health Organization, 2013, Feb-01, Volume: 91, Issue:2

    Topics: Cost-Benefit Analysis; Counseling; Developing Countries; Global Health; Harm Reduction; Hepatitis C;

2013
HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Adult; Asian People; China; Female; Hepatitis C; HIV Infections; Humans; Male; Mass Screening; Metha

2013
Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.
    Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists, 2013, Volume: 5, Issue:3

    Topics: Adult; China; Comorbidity; Depression; Female; Hepatitis C; Humans; Male; Methadone; Middle Aged; Op

2013
Hepatitis C virus infection influences the S-methadone metabolite plasma concentration.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cell Line, Transformed; Cytochrome P-450 CYP2B6; Demography; D

2013
HIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infections.
    BMC public health, 2013, Sep-30, Volume: 13

    Topics: Adult; China; Cross-Sectional Studies; Drug Users; Female; Hepatitis C; HIV Infections; Humans; Male

2013
High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Adult; Analgesics, Opioid; China; Coinfection; Comorbidity; Female; Hepatitis C; HIV Infections; Hum

2013
[Study on the incidence and risk factors of HCV infection among heroin addicts who were on methadone maintenance treatment in Dehong prefecture,Yunnan province].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2013, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Aged; China; Cohort Studies; Drug Users; Female; Hepatitis C; Humans; Incidence;

2013
Long-term effects of methadone maintenance treatment with different psychosocial intervention models.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; China; Counseling; Female; Follow-Up Studies; Hepatitis C; HIV; HIV Infections; Humans; Male;

2014
Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.
    Drug and alcohol dependence, 2014, Apr-01, Volume: 137

    Topics: Adult; Asian People; Cognition Disorders; Female; Hepatitis C; Humans; Male; Methadone; Neuropsychol

2014
Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adult; Analgesics, Opioid; Coinfection; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C Ant

2014
The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China.
    BMC infectious diseases, 2014, Mar-10, Volume: 14

    Topics: Adult; China; Coinfection; Drug Users; Female; Geography, Medical; Hepatitis C; HIV Infections; Huma

2014
Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel.
    Substance abuse, 2014, Volume: 35, Issue:3

    Topics: Adult; Female; Hepatitis C; HIV Seroprevalence; Humans; Israel; Male; Methadone; Opiate Substitution

2014
Evaluation of state opioid substitution treatment program in Georgia.
    Georgian medical news, 2014, Issue:229

    Topics: Adult; Aged; Alcoholism; Buprenorphine; Female; Georgia (Republic); Government Programs; Hepatitis B

2014
Substance use and hepatitis C: an ecological momentary assessment study.
    Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2014, Volume: 33, Issue:7

    Topics: Adult; Affect; Antiviral Agents; Cocaine-Related Disorders; Craving; Female; Hepatitis C; Heroin Dep

2014
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.
    Addiction (Abingdon, England), 2014, Volume: 109, Issue:12

    Topics: Adult; Alcoholism; British Columbia; Cohort Studies; Female; Hepatitis C; Humans; Illicit Drugs; Mal

2014
Hepatitis B and C prevalence among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Pereira, Colombia.
    Journal of infection in developing countries, 2014, Sep-12, Volume: 8, Issue:9

    Topics: Adult; Colombia; Female; Hepatitis B; Hepatitis C; Heroin Dependence; Humans; Male; Methadone; Preva

2014
Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    JAMA internal medicine, 2014, Volume: 174, Issue:12

    Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Disease Transmission, Infectious; Drug Users; Fema

2014
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.
    Addiction (Abingdon, England), 2015, Volume: 110, Issue:5

    Topics: Adult; China; Cross-Sectional Studies; Female; Hepatitis C; Humans; Male; Methadone; Opiate Substitu

2015
Who uses methadone services in China? Monitoring the world's largest methadone programme.
    Addiction (Abingdon, England), 2015, Volume: 110 Suppl 1

    Topics: Adult; Analgesics, Opioid; China; Cohort Studies; Database Management Systems; Drug Users; Female; H

2015
A model for treating HCV hepatitis in patients receiving methadone maintenance therapy.
    The Israel journal of psychiatry and related sciences, 2014, Volume: 51, Issue:4

    Topics: Adult; Antiviral Agents; Comorbidity; Hepatitis C; Humans; Interferon-alpha; Methadone; Narcotics; O

2014
Commentary on Zhou et al. (2015): Research on methadone maintenance treatment (MMT) as prevention for HCV infection--MMT is not a single variable.
    Addiction (Abingdon, England), 2015, Volume: 110, Issue:5

    Topics: Hepatitis C; Humans; Methadone; Narcotics; Opiate Substitution Treatment

2015
Factors associated with methadone treatment duration: a Cox regression analysis.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: Adult; Demography; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone;

2015
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients.
    International journal of cardiology, 2015, Sep-01, Volume: 194

    Topics: Adult; Chemokine CXCL10; Chemokines; Electrocardiography; Female; Hepatitis C; Heroin Dependence; HI

2015
Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
    Drug and alcohol dependence, 2015, Aug-01, Volume: 153

    Topics: Adult; Buprenorphine; Case-Control Studies; Coinfection; Female; Hepatitis C; HIV Infections; Humans

2015
Simeprevir-induced severe withdrawal syndrome in an HIV/HCV coinfected patient on long-term maintenance methadone therapy.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:8

    Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Interactions; Hepatitis C

2015
"Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.
    Drug and alcohol dependence, 2015, Aug-01, Volume: 153

    Topics: Adult; Analgesics, Opioid; Drug Users; Female; Hepatitis C; Humans; Male; Methadone; Middle Aged; Op

2015
Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.
    BMJ open, 2015, Aug-21, Volume: 5, Issue:8

    Topics: Adult; Analgesics, Opioid; China; Drug Users; Female; Follow-Up Studies; Hepatitis C; HIV Infections

2015
[Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2015, Volume: 36, Issue:8

    Topics: China; Coinfection; Drug Users; Hepatitis C; HIV Infections; Humans; Methadone; Opiate Substitution

2015
Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adolescent; Adult; China; Drug Users; Female; Geography; Hepatitis C; Hepatitis C Antibodies; Humans

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
    AIDS care, 2016, Volume: 28, Issue:10

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Cross-Sectional Studies; Female; Health Services Accessibili

2016
The physical health of people who inject drugs: complexities, challenges, and continuity.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2016, Volume: 66, Issue:647

    Topics: Antiviral Agents; Delivery of Health Care; Disease Transmission, Infectious; General Practice; Healt

2016
[Tracing hepatitis C virus transmission by using high-throughput sequencing technique].
    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 2016, Volume: 50, Issue:6

    Topics: Adult; Antibodies, Viral; China; Contact Tracing; Genetic Variation; Genotype; Hepacivirus; Hepatiti

2016
[HCV infection status and related risk factors in drug users under HIV sentinel surveillance in Henan province, 2011-2015].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2016, Volume: 37, Issue:6

    Topics: China; Cross-Sectional Studies; Drug Users; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Hum

2016
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.
    PloS one, 2016, Volume: 11, Issue:11

    Topics: Adult; Antipsychotic Agents; Antiviral Agents; Benzodiazepines; Buprenorphine, Naloxone Drug Combina

2016
Population dynamics of hepatitis C virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform.
    Journal of viral hepatitis, 2017, Volume: 24, Issue:7

    Topics: Adult; Analgesics, Opioid; China; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Male; Methadon

2017
Hepatitis C in a Mobile Low-Threshold Methadone Program.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:6

    Topics: Adult; Aged; Alcohol-Related Disorders; Coinfection; Comorbidity; Cross-Sectional Studies; Drug User

2017
Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Journal of substance abuse treatment, 2017, Volume: 76

    Topics: Adult; Buprenorphine; Continuity of Patient Care; Female; Hepatitis C; Humans; Male; Methadone; Midd

2017
Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
    Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:9

    Topics: Adult; Alcohol Drinking; Biomarkers; Esters; Ethanol; Female; Glucuronates; Hair; Hepatitis C; Human

2008
Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings.
    Australian health review : a publication of the Australian Hospital Association, 2008, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Hepatitis C;

2008
Implementation of drug substitution therapy in Georgia.
    Central European journal of public health, 2008, Volume: 16, Issue:3

    Topics: Georgia (Republic); Harm Reduction; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Psych

2008
Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection.
    Journal of addictive diseases, 2008, Volume: 27, Issue:4

    Topics: Adult; Aged; Alcoholism; Analgesics, Opioid; Attitude of Health Personnel; Delivery of Health Care;

2008
Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Drug and alcohol dependence, 2009, May-01, Volume: 101, Issue:3

    Topics: Adult; Depression; Ethnicity; Health Status; Hepatitis C; Humans; Mental Health; Methadone; Middle A

2009
Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.
    Substance use & misuse, 2009, Volume: 44, Issue:4

    Topics: Adult; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Hepatitis C; Humans;

2009
Treatment of hepatitis C infection for current or former substance abusers in a community setting.
    Journal of viral hepatitis, 2009, Volume: 16, Issue:8

    Topics: Adult; Antiviral Agents; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Me

2009
Prevalence of problem alcohol use among patients attending primary care for methadone treatment.
    BMC family practice, 2009, Jun-11, Volume: 10

    Topics: Adult; Alcoholism; Analgesics, Opioid; Cross-Sectional Studies; Female; Hepatitis C; Heroin Dependen

2009
[A study of mix-infections with different genotypes of hepatitis C virus in patients from a methadone maintenance clinic in Wuhan].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2009, Volume: 30, Issue:2

    Topics: Adult; China; Genes, Viral; Genotype; Hepacivirus; Hepatitis C; Humans; Methadone; Middle Aged; Opio

2009
Screening for hepatitis C virus infection in methadone-maintained mothers and their infants.
    The Medical journal of Australia, 2009, Nov-16, Volume: 191, Issue:10

    Topics: Adult; Analgesics, Opioid; Female; Hepatitis C; Humans; Infant; Infant, Newborn; Methadone; Neonatal

2009
Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
    Substance use & misuse, 2010, Volume: 45, Issue:1-2

    Topics: Adult; Drug Users; Female; Health Knowledge, Attitudes, Practice; Hepatitis C; Humans; Israel; Male;

2010
Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Journal of viral hepatitis, 2010, Volume: 17, Issue:12

    Topics: Adolescent; Adult; Attitude of Health Personnel; Delivery of Health Care; Female; Health Knowledge,

2010
Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
    European journal of epidemiology, 2010, Volume: 25, Issue:2

    Topics: Adult; Antibodies, Viral; Australia; Enzyme-Linked Immunosorbent Assay; Female; Health Behavior; Hep

2010
Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
    Substance use & misuse, 2010, Volume: 45, Issue:4

    Topics: Adult; Female; Health Knowledge, Attitudes, Practice; Hepatitis C; Humans; Male; Methadone; Patient

2010
Select barriers to harm-reduction services for IDUs in eastern Europe.
    Central European journal of public health, 2009, Volume: 17, Issue:4

    Topics: Age Factors; Confidentiality; Europe, Eastern; Fees and Charges; Harm Reduction; Health Services Acc

2009
Improvement in hepatopulmonary syndrome after methadone withdrawal: a case report with implications for disease mechanism.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:7

    Topics: Hepatitis C; Hepatopulmonary Syndrome; Humans; Liver Cirrhosis; Male; Methadone; Middle Aged; Narcot

2010
Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere.
    Drug and alcohol dependence, 2011, Jan-15, Volume: 113, Issue:2-3

    Topics: Antiviral Agents; Australia; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Methadone; M

2011
Scaling up the national methadone maintenance treatment program in China: achievements and challenges.
    International journal of epidemiology, 2010, Volume: 39 Suppl 2

    Topics: China; Crime; Health Education; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Methadone; N

2010
Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.
    Journal of viral hepatitis, 2012, Volume: 19, Issue:1

    Topics: Adult; Antiviral Agents; Behavior, Addictive; Disease Management; Female; Genotype; Hepacivirus; Hep

2012
Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.
    Drug and alcohol dependence, 2011, Jul-01, Volume: 116, Issue:1-3

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV

2011
The establishment of a methadone treatment clinic for women in Tehran, Iran.
    Journal of public health policy, 2011, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Analgesics, Opioid; Female; Harm Reduction; Hepatitis

2011
Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan.
    Substance abuse treatment, prevention, and policy, 2011, Apr-08, Volume: 6

    Topics: Adult; Dose-Response Relationship, Drug; Female; Hepatitis C; Heroin Dependence; HIV Seronegativity;

2011
The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
    Journal of medical virology, 2011, Volume: 83, Issue:7

    Topics: Adult; Age Factors; Cluster Analysis; Drug Administration Schedule; Drug Users; Female; Genotype; He

2011
A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Addictive behaviors, 2011, Volume: 36, Issue:12

    Topics: Adult; Aged, 80 and over; Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Heroin Dependence; HI

2011
Low risk for hepatitis C seroconversion in methadone maintenance treatment.
    Journal of addiction medicine, 2011, Volume: 5, Issue:3

    Topics: Adult; Age Distribution; Benzodiazepines; Cohort Studies; Comorbidity; Female; Follow-Up Studies; He

2011
Characteristics of Iranian women seeking drug treatment.
    Journal of women's health (2002), 2011, Volume: 20, Issue:11

    Topics: Adolescent; Adult; Analysis of Variance; Female; Health Status; Hepatitis C; HIV Infections; Humans;

2011
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
    Maturitas, 2011, Volume: 70, Issue:3

    Topics: Adult; Age Factors; Body Mass Index; Bone Density; Bone Resorption; Female; Hepatitis C; HIV Infecti

2011
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.
    Journal of substance abuse treatment, 2012, Volume: 42, Issue:4

    Topics: Cross-Sectional Studies; Guidelines as Topic; Health Services; Health Services Accessibility; Hepati

2012
Attitudes of methadone program staff toward provision of harm-reduction and other services.
    Journal of addiction medicine, 2011, Volume: 5, Issue:4

    Topics: Adult; AIDS Serodiagnosis; Attitude of Health Personnel; Data Collection; Delivery of Health Care; F

2011
The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Social science & medicine (1982), 2012, Volume: 74, Issue:2

    Topics: Ambulatory Care Facilities; Antiviral Agents; Australia; Cross-Sectional Studies; Female; Health Car

2012
Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China.
    Journal of public health (Oxford, England), 2012, Volume: 34, Issue:1

    Topics: Adult; Analysis of Variance; China; Female; Health Knowledge, Attitudes, Practice; Hepacivirus; Hepa

2012
A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.
    Substance use & misuse, 2012, Volume: 47, Issue:1

    Topics: Counseling; Hepacivirus; Hepatitis C; Humans; Israel; Methadone; Motivation; Patient Acceptance of H

2012
Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:3

    Topics: Adult; Alcohol Drinking; Antiviral Agents; China; Cross-Sectional Studies; Female; Health Knowledge,

2012
Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.
    Journal of substance abuse treatment, 2013, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Attitude of Health Personnel; Educational Status; Female; Hepatitis C; Humans; Ma

2013
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
    Substance abuse treatment, prevention, and policy, 2012, Mar-20, Volume: 7

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Arrhythmias, Cardiac; Drug Interactions; Female;

2012
Finasteride and methadone use and risk of advanced hepatitis C related liver disease.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Cross-Sectional Studies; Finasteride; Hepatitis C; Humans

2012
HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.
    The American journal of drug and alcohol abuse, 2012, Volume: 38, Issue:6

    Topics: Adult; AIDS Serodiagnosis; Cross-Sectional Studies; Female; Hepatitis C; HIV Infections; HIV Seroneg

2012
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    The International journal on drug policy, 2012, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Cross-Sectional Studies; Female; Harm Reduction; Hepatitis C; Humans; Incidence;

2012
Methadone maintenance treatment in China: perceived challenges from the perspectives of service providers and patients.
    Journal of public health (Oxford, England), 2013, Volume: 35, Issue:2

    Topics: Adult; Attitude of Health Personnel; Attitude to Health; China; Female; Focus Groups; Health Service

2013
HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Adult; China; Female; Hepatitis C; Heroin Dependence; HIV Infections; Humans; Male; Methadone; Middl

2012
High prevalence of HIV, syphilis and HCV, and low methadone maintenance treatment in a migrant population in Beijing.
    Journal of addiction medicine, 2012, Volume: 6, Issue:4

    Topics: Adult; China; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Health Services Acc

2012
Unprotected sex among HIV-positive treatment-seeking opioid-dependent adults in China: a cross-sectional study.
    Sexually transmitted diseases, 2012, Volume: 39, Issue:12

    Topics: Adult; China; Cross-Sectional Studies; Female; Government Programs; Health Behavior; Hepatitis C; HI

2012
Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    The International journal on drug policy, 2013, Volume: 24, Issue:6

    Topics: Administration, Oral; Analgesics, Opioid; Attitude of Health Personnel; Drug Administration Schedule

2013
Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
    BMC public health, 2012, Dec-11, Volume: 12

    Topics: Adult; Coinfection; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hepatitis C;

2012
Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.
    Journal of addictive diseases, 2002, Volume: 21, Issue:4

    Topics: Adult; Comorbidity; Hepatitis C; HIV Infections; HIV-1; Humans; Methadone; New York; Substance Abuse

2002
Methadone maintenance expands inside federal prisons.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002, Nov-12, Volume: 167, Issue:10

    Topics: Analgesics, Opioid; Canada; Hepatitis C; HIV Infections; Human Rights; Humans; Methadone; Opioid-Rel

2002
What's new for injection drug users with HIV infection?
    Sexually transmitted infections, 2003, Volume: 79, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Outbreaks; Drug Interactions; Health

2003
[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment].
    Medicina clinica, 2003, May-31, Volume: 120, Issue:20

    Topics: Adult; Analgesics, Opioid; Cohort Studies; Female; Hepatitis C; HIV Infections; Humans; Male; Methad

2003
[Prevalence of serological markers of viral hepatitis B and hepatitis C in drug-dependent individuals treated at the Drop Methadone Center in Prague].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:4

    Topics: Adult; Czech Republic; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Male; Methadone; Middl

2003
Gaps in the drug-free and methadone treatment program response to Hepatitis C.
    Journal of substance abuse treatment, 2003, Volume: 24, Issue:4

    Topics: Health Care Surveys; Health Services Accessibility; Hepatitis C; Humans; Methadone; Opioid-Related D

2003
Finding a vein or obtaining consent: a qualitative study of hepatitis C testing in GP methadone clinics.
    Family practice, 2003, Volume: 20, Issue:5

    Topics: Attitude of Health Personnel; Coercion; Hepatitis C; Humans; Informed Consent; Interviews as Topic;

2003
Liver transplantation for methadone-maintained opiate dependents: making the case for cautious optimism.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:10

    Topics: Contraindications; Female; Hepatitis C; Humans; Liver Transplantation; Male; Methadone; Narcotics; O

2003
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2004, Volume: 10, Issue:1

    Topics: Adult; Analgesics, Opioid; Comorbidity; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Transpla

2004
A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
    Drug and alcohol dependence, 2004, Mar-08, Volume: 73, Issue:3

    Topics: Health Care Surveys; Health Services Accessibility; Health Services Research; Hepatitis C; Hepatitis

2004
The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2004, Volume: 81, Issue:1

    Topics: Analgesics, Opioid; Health Care Surveys; Health Education; Hepatitis C; Humans; Methadone; Program E

2004
What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?
    Drug and alcohol review, 2004, Volume: 23, Issue:3

    Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis C; Humans; Male; Markov Chains; Me

2004
Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Wiener klinische Wochenschrift, 2004, Volume: 116 Suppl 2

    Topics: Adult; Age Factors; Cross-Sectional Studies; Female; Flaviviridae Infections; GB virus C; Hepatitis

2004
[The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001].
    Presse medicale (Paris, France : 1983), 2004, Oct-23, Volume: 33, Issue:18 Suppl

    Topics: Adult; Age Distribution; Buprenorphine; Cohort Studies; Drug Overdose; Female; France; Hallucinogens

2004
Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
    The American journal of drug and alcohol abuse, 2004, Volume: 30, Issue:4

    Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Combined Modality Therapy; Comorbidity; Cultur

2004
Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.
    Australian and New Zealand journal of public health, 2004, Volume: 28, Issue:6

    Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Drug Therapy, Combination; Female; Hepatit

2004
Treating hepatitis C virus infection in active substance users.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40 Suppl 5

    Topics: Female; Hepatitis C; Humans; Male; Mental Disorders; Methadone; Middle Aged; Substance Abuse, Intrav

2005
Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40 Suppl 5

    Topics: Adult; Aged; Delivery of Health Care, Integrated; Eligibility Determination; Female; Hepatitis C; Hu

2005
Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Journal of substance abuse treatment, 2005, Volume: 28, Issue:2

    Topics: Adult; Comorbidity; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Health S

2005
Experience of hepatitis C among current or former heroin users attending general practice.
    Irish medical journal, 2005, Volume: 98, Issue:3

    Topics: Adolescent; Adult; Alcohol Drinking; Comorbidity; Family Practice; Female; Health Knowledge, Attitud

2005
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:7

    Topics: Adult; Australia; Disease Transmission, Infectious; Female; Follow-Up Studies; Hepacivirus; Hepatiti

2005
Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.
    International journal of methods in psychiatric research, 2005, Volume: 14, Issue:1

    Topics: Buprenorphine; Cohort Studies; Comorbidity; Cross-Sectional Studies; Dose-Response Relationship, Dru

2005
Feasibility and outcome of HCV treatment in a Canadian federal prison population.
    American journal of public health, 2005, Volume: 95, Issue:10

    Topics: Adult; British Columbia; DNA, Viral; Drug Combinations; Feasibility Studies; Federal Government; Gen

2005
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.
    Journal of substance abuse treatment, 2005, Volume: 29, Issue:3

    Topics: Delivery of Health Care; Female; Hepatitis C; Heroin Dependence; Humans; Male; Mental Disorders; Met

2005
Linkage with methadone treatment upon release from incarceration: a promising opportunity.
    Journal of addictive diseases, 2005, Volume: 24, Issue:3

    Topics: Crime; Health Services Needs and Demand; Hepatitis B; Hepatitis C; HIV Infections; Humans; Long-Term

2005
Dental management of patients taking methadone.
    Dental update, 2005, Volume: 32, Issue:8

    Topics: Dental Care; Dental Caries; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Opioid-Relate

2005
[Quality assurance in patient addiction treated with drug substitution].
    Krankenpflege Journal, 2005, Volume: 43, Issue:7-10

    Topics: Antiviral Agents; Buprenorphine; Comorbidity; Drug Information Services; Drug Interactions; Drug The

2005
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Drug and alcohol dependence, 2006, Sep-15, Volume: 84, Issue:2

    Topics: Adult; Anti-Retroviral Agents; British Columbia; Cohort Studies; Comorbidity; Demography; Female; Fo

2006
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
    Journal of substance abuse treatment, 2006, Volume: 30, Issue:4

    Topics: Adult; Anti-HIV Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; N

2006
HIV sexual risk behaviors among injection drug users in Shanghai.
    Drug and alcohol dependence, 2006, Volume: 82 Suppl 1

    Topics: Adult; Catchment Area, Health; China; Cross-Sectional Studies; Demography; Female; Hepatitis B; Hepa

2006
Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    The Israel journal of psychiatry and related sciences, 2006, Volume: 43, Issue:2

    Topics: Ambulatory Care; Female; Hepatitis C; HIV Infections; Humans; Israel; Male; Mental Disorders; Methad

2006
[Health related quality of life among HIV-HCV co-infected patients].
    Revue d'epidemiologie et de sante publique, 2006, Volume: 54 Spec No 1

    Topics: Adult; Anti-Retroviral Agents; Buprenorphine; Cohort Studies; Counseling; Data Interpretation, Stati

2006
[Pharmacy syringe exchange program for injection drug users].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 1

    Topics: Adult; Data Collection; France; Hepatitis C; Humans; Methadone; Middle Aged; Narcotics; Needle Shari

2006
Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
    Journal of psychoactive drugs, 2006, Volume: 38, Issue:3

    Topics: Ambulatory Care; Attitude of Health Personnel; Data Interpretation, Statistical; Hepatitis C; Humans

2006
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
    Substance abuse treatment, prevention, and policy, 2007, Feb-01, Volume: 2

    Topics: Adult; Analgesics, Opioid; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interfe

2007
Zopiclone misuse: an update from Dublin.
    Drug and alcohol review, 2007, Volume: 26, Issue:1

    Topics: Adult; Azabicyclo Compounds; Benzodiazepines; Comorbidity; Cross-Sectional Studies; Female; Hepatiti

2007
Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    The European journal of general practice, 2007, Volume: 13, Issue:1

    Topics: Adult; Aged; Family Practice; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Illicit Drug

2007
Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Drug and alcohol review, 2007, Volume: 26, Issue:4

    Topics: Analgesics, Opioid; Harm Reduction; Health Promotion; Hepacivirus; Hepatitis C; Humans; Methadone; N

2007
Body composition, gender, and illicit drug use in an urban cohort.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:3

    Topics: Baltimore; Black People; Body Composition; Body Mass Index; Cocaine-Related Disorders; Comorbidity;

2007
A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:4

    Topics: Adult; Age Factors; Amphetamine-Related Disorders; British Columbia; Cocaine-Related Disorders; Comm

2007
Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.
    The International journal on drug policy, 2007, Volume: 18, Issue:4

    Topics: Anti-HIV Agents; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Methadone; Narc

2007
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Addiction (Abingdon, England), 2007, Volume: 102, Issue:9

    Topics: Adult; Cohort Studies; Female; Harm Reduction; Hepatitis C; HIV Infections; Humans; Incidence; Male;

2007
Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:3

    Topics: Antiviral Agents; Drug Implants; Hepatitis C; Humans; Methadone; Morphine Dependence; Naltrexone; Na

2007
Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
    Journal of acquired immune deficiency syndromes (1999), 2007, Nov-01, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Cocaine-Related Disorders; Cross-Sectional Studies; Female; Hepatit

2007
Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    The American journal of drug and alcohol abuse, 2007, Volume: 33, Issue:5

    Topics: Adult; AIDS Serodiagnosis; Antipsychotic Agents; Cocaine-Related Disorders; Cross-Sectional Studies;

2007
Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.
    Journal of substance abuse treatment, 2008, Volume: 35, Issue:1

    Topics: Adult; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Risk-Taking; Sexual Behavior; S

2008
High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2008, Volume: 41, Issue:4

    Topics: Cohort Studies; Female; Hepatitis C; Hepatitis C Antibodies; Hong Kong; Humans; Male; Methadone; Mid

2008
Buprenorphine injection in Melbourne, Australia--an update.
    Drug and alcohol review, 2008, Volume: 27, Issue:2

    Topics: Australia; Buprenorphine; Catchment Area, Health; Cohort Studies; Cross-Sectional Studies; Harm Redu

2008
Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    The New Zealand medical journal, 1995, Sep-08, Volume: 108, Issue:1007

    Topics: Adult; Blood Donors; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Male; Methadone; Narcotics

1995
Hepatitis C virus infection among a cohort of Victorian injecting drug users.
    The Medical journal of Australia, 1993, Aug-16, Volume: 159, Issue:4

    Topics: Adult; Cohort Studies; DNA, Viral; Female; Hepacivirus; Hepatitis Antibodies; Hepatitis C; Hepatitis

1993
A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
    European journal of epidemiology, 1993, Volume: 9, Issue:3

    Topics: Adult; Comorbidity; Condoms; Female; Germany; Hepatitis B; Hepatitis C; HIV Infections; Homosexualit

1993
Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus.
    Australian and New Zealand journal of public health, 1997, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Female; Hepatitis C; Humans; Incidence; Male; Methadone; Middle Aged; Prevalence;

1997
Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Addiction (Abingdon, England), 1997, Volume: 92, Issue:8

    Topics: Adult; Female; Hepatitis C; Humans; Male; Methadone; Middle Aged; Narcotics; Substance Abuse, Intrav

1997
Truncated recurrent event survival models for methadone data.
    Biometrics, 1997, Volume: 53, Issue:4

    Topics: Biometry; Female; Hepatitis C; Heroin Dependence; HIV Seropositivity; Humans; Likelihood Functions;

1997
Addiction treatment: promoting a medical approach to substance use.
    Journal of urban health : bulletin of the New York Academy of Medicine, 1998, Volume: 75, Issue:3

    Topics: Blood-Borne Pathogens; Delivery of Health Care, Integrated; Financial Support; Health Promotion; Hea

1998
Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
    AIDS (London, England), 1998, Oct-22, Volume: 12, Issue:15

    Topics: Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Male; Methadone

1998
Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic.
    Addiction (Abingdon, England), 1999, Volume: 94, Issue:10

    Topics: Adult; Benzodiazepines; Female; Hepatitis C; HIV Infections; Humans; Israel; Male; Methadone; Narcot

1999
[Axillary plexus catheter block in accidental intra-arterial levomethadone HCl injection in an HIV-positive, hepatitis B and C active drug dependent patient].
    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..., 2000, Volume: 32, Issue:3

    Topics: Adult; Amides; Anesthetics, Local; Arm; Axillary Artery; Blood Flow Velocity; Brachial Plexus; Cathe

2000
Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.
    Journal of urban health : bulletin of the New York Academy of Medicine, 2000, Volume: 77, Issue:3

    Topics: Adult; Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Male; Me

2000
Dilated bile duct in patients receiving narcotic substitution: an early report.
    Journal of clinical gastroenterology, 2000, Volume: 31, Issue:2

    Topics: Adult; Bile Duct Diseases; Bile Ducts; Biopsy; Buprenorphine; Common Bile Duct; Common Bile Duct Dis

2000
Former addicts face barriers to treatment for HCV.
    JAMA, 2001, Feb-28, Volume: 285, Issue:8

    Topics: Health Services Accessibility; Hepatitis C; Humans; Methadone; Narcotics; Practice Guidelines as Top

2001
Liver transplantation and opioid dependence.
    JAMA, 2001, Feb-28, Volume: 285, Issue:8

    Topics: Hepatitis C; Humans; Liver Transplantation; Methadone; Narcotics; Opioid-Related Disorders; Patient

2001
Hepatitis C in methadone maintenance patients: prevalence and public policy implications.
    Journal of addictive diseases, 2001, Volume: 20, Issue:1

    Topics: Adult; Aged; Asian; California; Comorbidity; Cross-Sectional Studies; Female; Health Policy; Hepatit

2001
Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts.
    Journal of addictive diseases, 2001, Volume: 20, Issue:1

    Topics: Carrier State; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Heroin Dependence; Humans; Liver

2001
Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    The New Zealand medical journal, 2001, Jul-27, Volume: 114, Issue:1136

    Topics: Adult; Comorbidity; Cross-Sectional Studies; Feasibility Studies; Female; Hepatitis B; Hepatitis B V

2001
A reduction in HIV positive and an increase in hepatitis C positive subjects in methadone maintenance treatments.
    Swiss medical weekly, 2001, Jul-14, Volume: 131, Issue:27-28

    Topics: Cross-Sectional Studies; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related D

2001
HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme.
    European journal of public health, 2001, Volume: 11, Issue:4

    Topics: Adult; Drug Prescriptions; Female; Health Policy; Hepatitis B; Hepatitis C; Heroin; HIV Infections;

2001
Irish prison guards call for expansion of methadone access.
    Canadian HIV/AIDS policy & law review, 2001, Volume: 6, Issue:1-2

    Topics: Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Ireland; Methadone; Prisons

2001
Treating hepatitis C in methadone maintenance patients: an interim analysis.
    Drug and alcohol dependence, 2002, Jul-01, Volume: 67, Issue:2

    Topics: Adult; Aged; Chi-Square Distribution; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interf

2002
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.
    AIDS (London, England), 1992, Volume: 6, Issue:4

    Topics: Hepatitis B; Hepatitis C; HIV Infections; Humans; Incidence; Methadone; Substance Abuse, Intravenous

1992